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Rapid diagnosis of infectious disease at the site of the patient is critical for preventing the 
escalation of an outbreak into an epidemic. This is particularly true for cholera, a disease 
known to spread swiftly within resource-limited populations. A device suited to point-of- 
care (POC) diagnosis of cholera must not only demonstrate laboratory levels of 
sensitivity and specificity, but it must do so in a highly portable, low-cost manner, with a 
simplistic readout. Here, we report novel proof-of-concept lab-on-a-chip (LOC) elec- 
trochemical immunosensors for the detection of cholera toxin subunit B (CTX), based on 
two nanostructured architectures: the gold dendritic array, and the extended core coax 
(ECC).  
The dendritic array has an ~18x greater surface area than a planar gold counterpart, per 
electrochemical measurements, allowing for a higher level of diagnostic sensitivity. An 
electrochemical enzyme-linked immunosorbant assay (ELISA) for CTX performed via 
differential pulse voltammetry (DPV) on the dendritic sensor demonstrated a limit-of- 
detection of 1 ng mL-1, per a signal-to-noise ratio of 2.6, which was more sensitive than 
a simple planar gold electrode (100 ng mL-1). This sensitivity also matches a currently 
available diagnostic standard, the optical ELISA, but on a miniaturized platform with 
simple electrical readout.  
The ECC was optimized and explored, undergoing several changes in design to facili- 
tate sensitive LOC electrochemical detection. The ECC matched the off-chip sensitivity 
towards CTX demonstrated by a previous non-extended core coaxial iteration, which was 
comparable to a standard optical ELISA. In contrast to the previous coaxial architecture, 
the ECC is amenable to functionalization of the gold core, allowing for LOC detection. 
ECCs were functionalized using a thiolated protein G, and CTX was detected via an 
electrochemical ELISA. While this work is ongoing, the ECC shows promise as a 
platform for LOC electrochemical ELISA.  
The ability to potentially meet POC demands makes biofunctionalized gold dendrites and 
ECCs promising architectures for further development as LOC sensors for the de- tection 
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1.1 Cholera remains a global disease burden
The World Health Organization (WHO) describes cholera as "a disease of in-
equity - an ancient illness that today sickens and kills only the poorest and most
vulnerable people" (1). Indeed, for close to a century, industrialized countries
have seen almost no cholera outbreaks, largely due to modern sanitation infras-
tructure. Despite this, cholera remains a global disease burden affecting ~2.9
million people per year, resulting in ~95,000 deaths (1). The map of reported
cholera cases from the last decade could as well be a map of poverty (Fig. 1.1).
It is for this reason that the world is currently in the midst of the 7th pandemic
of cholera which has persisted since 1961 despite the availability of highly ef-
fective treatment, preventative measures, and even vaccines (2, 3). The endemic
presence of cholera in many parts of the world, and the frequent re-emergence
of large scale cholera outbreaks, means that strategies for containment that were
effective in the developed world must be reevaluated.
2 Chapter 1. Introduction
FIGURE 1.1: A map of areas reposting cholera outbreaks from
2010 to 2014. Image from reference (1).
1.1.1 Causative agent and pathogenesis
Vibrio cholerae is a gram-negative, highly motile rod-shaped bacterium of the
Vibrionaceae family. It thrives in salt water, but can also be found in low-
salinity water if it is warm and contains sufficient nutrients (4). While there
are hundreds of serogroups of V. cholerae, only two, O1 and O139, are known
to cause epidemics (5). Infection occurs via a fecal-oral transmission, usually
from contaminated drinking water, but also through contaminated food. Once
ingested, most V. cholerae is destroyed by the stomach’s gastric juices. As is the
case in areas where cholera is endemic, if a person is malnourished, the stom-
ach produces less acid and the bacteria survives to colonize the small intestine
(6). Cholera enterotoxin is secreted and adheres to the cells of intestine via an
interation between the toxin’s pentameric β subunit and the GM1 ganglioside of
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the enterocyte. Once attached, the toxin’s single α subunit is cleaved into two
domains, A1 and A2, after which the enzymatic A1 subunit enters the cell where
it continuously stimulates the production of cAMP. High cAMP levels lead to
activation of the cystic fibrosis transmembrane conductance regulator (CFTR),
an ATP-gated anion channel, which allows for an efflux of Cl- ions and water (7,
8). This leads to the acute "rice water" diarrhea characteristic of cholera, which
can cause death within hours if untreated (9).
1.1.2 Early detection and response to prevent outbreaks
The WHO has recently developed a roadmap for the elimination of cholera
worldwide by the year 2030. Given the ample knowledge about both the preven-
tion and treatment of its infections, it is a reality that every death from cholera is
avoidable. However, it still continues to thrive in crowded, resource-limited ar-
eas of the world with suboptimal centralized health care and sanitation facilities
(10). Additionally, it disproportionately strikes communities already weakened
by famine, war and natural disasters. For example, after an earthquake dev-
astated Haiti in 2010, an epidemic of cholera was able to spread so rapidly that
only 2 months after the first laboratory-confirmation case, it had affected 120,000
people, with 2,500 deaths reported (11).
Fundamental to the WHO’s roadmap is the importance of early detection and
rapid response to control future outbreaks. In fact, this comprises "Axis 1" of
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the plan, highlighting that early detection is the foundation for preventing epi-
demics. However, a lack of sophisticated medical infrastructure available to the
people most affected by cholera means that any potential diagnostic tool must
meet the demands unique to this environment. This means that for a tool to be
useful at the point-of-care (POC) in a resource-limited area, it must also be low-
cost, portable, and give unambiguous results that could be easily interpreted by
untrained personnel, in addition to being highly sensitive and specific. An ideal
tool would also open up the possibility of transmitting diagnostic data to a cen-
tralized data bank for epidemiological monitoring. The WHO uses the acronym
A.S.S.U.R.E.D. to describe the characteristics necessary for an ideal POC diag-
nostic test (Fig. 1.2) (12, 13).
1.1.3 Current assays for cholera detection
Current benchmark assays for cholera detection do not meet POC diagnostic
demands. Fecal culturing remains the best method, as it allows for serogroup
distinction which is important for monitoring outbreaks. This method, however,
is time consuming, typically requiring 2 full days for cultures to develop (9,
14). As a result, true POC diagnosis typically is made on the basis of symp-
toms, which for diarrheal diseases tend to be almost identical (14). This creates
a scenario where already limited resources, both financial and medical, may be
wasted on incorrect diagnosis. In turn, this contributes to the cycle of cholera
and poverty that is responsible for endemic infection in the first place (Fig. 1.3).
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FIGURE 1.2: The acronym A.S.S.U.R.E.D. is used to describe
the ideal features of a POC diagnostic device, as dictated by the
WHO.
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While breaking free of this cycle can be accomplished through interventions
at several points, the role of roper diagnosis in the prevention of the spread of
cholera is essential.
Cholera outbreaks account for an estimated $2 billion financial burden in the
countries it affects. This is mainly in the form of loss of productivity from pro-
longed convalescence and the death of otherwise healthy workers (1). Enhanced
epidemiological surveillance, facilitated by sensitive detection, allows for quick
identification of endemic areas, which directs medical response and may de-
crease the total monetary loss from a large outbreak.
To this end, since 1990, 24 commercially available cholera diagnostic tests have
been developed. Many of these are polymerase chain reactions (PCR) or ELISA-
based, which provide high levels of specificity and sensitivity. Yet both require
access to clinical laboratory infrastructure, which may be limited or nonexistent
at the site of the patient (15). Conversely, the most rapid and portable of these
24 tests all rely either on colorimetric lateral flow assays (LFA) or agglutination
readouts (16). Agglutination techniques are highly cost-effective and can give
rapid results, but are only semi-quantitative, and reagents require refrigeration
after reconstitution (17). LFAs (or "dipstick" tests) represent currently the most
promising technologies for POC diagnosis (18, 19). While low-cost and highly
user friendly, LFAs are qualitative or semi-quantitaive at best (20), and the sen-
sitivity and specificity of many available LFA tests are still not optimal (17).
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FIGURE 1.3: Cholera outbreaks in the developed world have
been unheard of in the last century. This is because poverty and
cholera are intrinsically linked.
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Further, LFAs rely on a visual readout with a colored strip appearing if suffi-
cient analyte is present in the test area. The drawback of such visual methods
was highlighed by Ley, et. al. in their review of one LFA tool, the Crystal VC
dipstick (Fig. 1.4) (21). They found that optical readouts increase the possibil-
ity of misdiagnoses by human error, such that the rate of false positives nearly
doubled, from 26% to 44%, when it was performed by workers in the field, vs. a
trained laboratory technician (22). In fact, it is recommended that the Crystal VC
dipstick not replace standard fecal culturing in diagnosis, but instead be used as
an intermediate tool for evaluating treatment options (23). As stated previously,
this can result in wasted time and resources, which contributes to the severity
of an outbreak. While at the present time LFA and agglutination assays may be
adequate, diagnostic sensors with simple, quantitative electrochemical readouts
may be more desirable towards outbreak prevention.
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FIGURE 1.4: The Crystal VC dipstick test provides an optical
readout similar to a pregnancy test. The reliance on colored strips
can lead to a high rate of misdiagnoses by workers in the field.
Image from reference (21).
1.2 Lab-on-a-chip sensors for POC diagnostics
Lab-on-a-chip (LOC) biosensors are those that integrate laboratory functions
onto a miniaturized chip-based platform (24). The field of biosensing is be-
ing revolutionized by LOC technology, with numerous fully integrated detection
systems utilizing a wide variety of sensing methods being reported recently (25–
30). In addition to being used as medical diagnostic tools, LOCs are being em-
ployed in pathogen detection (31), trace metal detection (32), water monitoring
(33), and in drug discovery (34). These devices, due to their size, function with
diminished reagent needs and, depending on their detection strategy, are often
low powered and highly portable. To this end, the use of LOC technologies are
particularly attractive as it pertains to public health care in the developing world,
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as these miniaturized tools hold the potential for sensitive, low-cost, POC diag-
nosis (35). While many advances have been made in the field, it remains largely
unproven outside of the laboratory, especially for POC applications.
LOC biosensors typically incorporate microfluidic technology to further remove
the human element from diagnosis (36). The field of microfluidics involves
the use of micrometer-scale microfabricated channels to manipulate the flow
of minute amounts of liquid, on the order of 10-9 to 10-18 liters (34, 37, 38).
The most frequently used elastomer for microfluidic channels, polydimethyl-
siloxane (PDMS), allows for manufacturing that is low-cost and high production
(39). Microfluidic channels integrated on a LOC biosensor therefore represent
a cost-effective alternative to LFAs for small-volume, user-friendly and poten-
tially automated detection at the site of the patient. The commercial promise
of the field is reflected in the number of patents issued for microfluidic devices,
which has been steadily increasing since the mid-90s (Fig. 1.5) (40). As the field
rapidly expands, new methods of miniaturizing conventional laboratory assays
are being explored. Detection strategies employed in LOC microfluidic sensors
have ranged from magnetic beads, to capillary electrophoresis, to electrochemi-
cal immunodetection (41–45). Microfluidics have also been utilized to decrease
the analysis time and reagent consumption of common immunoassays (46).
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FIGURE 1.5: The number of patents being issued for microflu-
idic devices reflects the commercial promise of the field. Image
from reference (40).
1.2.1 Optics-based LOC sensors
For diagnostic assays, tests with an optical readout mechanism are by far the
most prevalent (47). This includes the detection of either fluorescent tags or
color changes as a result of an enzymatic reaction (as in an ELISA); such tests
are called intensity assays. Optical detection also encapsulates the category of
surface plasmon resonance (SPR) assays. Intensity assays are more amenable
to portability, low cost and limited equipment needs, but the choice of detection
method is driven by a trade-off between POC benefits and diagnostic benefits,
which must be considered.
The use of a fluorescent signal in immunodetection is popular due to the com-
mercial availability of components required for detection (e.g. excitation source,
light collection apparatus and photodetector) (47). In addition to numerous
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available fluorophores, quantum dots (QD) also exist in a wide variety of emis-
sion spectra colors, and may in fact be more desirable as a reporter. QDs are
nanometer-scale semiconductor particles, whose unique optical and electronic
properties make them popular in LOC detection. When conjugated to biomolecules
(e.g. antibodies), QDs can provide ~100x reduced risk of photobleaching, and
20x the brightness as compared to a fluorophore (48). In fact, Jokerst, et. al.
were able to use QDs in a microfluidic biosensor in order to detect 3 cancer
biomarkers in both serum and whole saliva, with 30x more signal amplification
relative to a fluorphore (49). The color of the light emitted by a QD can be finely
tuned by only changing the particles’ size, shape or material (Fig. 1.6) (50, 51).
In this way, QDs allow for highly sensitive detection, such as the femtomolar
levels of cancer biomarker sensing achieved by Hu, et. al. (52). QDs remain
limited by their optical nature, however. They can experience a phenomenon
called "blinking", where the QD may become invisible due to surface defects
trapping electrons. Surface defects can also cause deterioration in quantum yield,
meaning that the ratio of absorption to emission is low, and they may become
undetectable, or may require much more sensitive instrumentation to detect (53).
Besides fluorescent and colorimetric assays, LOCs have also been reported that
take advantage of SPR. SPR is a method of exploiting the unique behavior of
metal surfaces wherein conduction electrons oscillate when excited by light, in
order to measure the adsorption of molecules onto the surface (54). This method
offers the POC advantages of being label-free, highly sensitive, and real-time
(55). Specifically, the resonance amplifies optical phenomena such as scattering,
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FIGURE 1.6: (a) The color of a QD emission can be finely tuned
by changing its size. (b) A wide range of extremely bright flu-
orescent colors are achievable using QDs. Images adapted from
references (a) (50) and (b) (51).
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transmission, adsorption (56, 57), and photoluminescence (58, 59).
SPR on flat metal films has been the most popular architecture for biosensing
applications, with commercially available sensors sold by GE Healthcare (60).
This system (Fig. 1.7), however, requires extremely large and expensive equip-
ment, making it unsuitable for use in POC work. Additionally, further drawbacks
to SPR sensing must be addressed, which include the inability to distinguish spe-
cific from non-specific binding at the sensor surface, inadequate sensitivity for
low molecular weight molecules, and the limited size of the sensor area (61).
On this latter point, altering the surface architecture of the sensor may offer a
solution. Research recently has focused on producing surface architectures with
their own interesting resonance behaviors, which can interface with portable mi-
crofluidic devices for POC diagnosis. Specifically, gold nanoparticles (AuNP)
have been particularly useful in LOC style sensors, which can increase sensor
surface area (62). Integration of SPR sensors with microfluidic channels to facil-
itate low volume and portable detection has also been extensively reported (63–
67). But despite the potential of optical detection methods like SPR and QDs,
the simple readout offered by electrochemical assays may be more desirable to-
wards POC applications.
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FIGURE 1.7: The GE Healthcare Biacore 8k SPR sensing plat-
form, used for assessing biomolecule interactions in drug discov-
ery. Image from reference (60).
1.2.2 Electrochemical LOC sensors
For medical purposes, tools that can offer a quantification of biological processes
are better suited than those that only offer qualitative data. Qualitative tools, such
as LFAs, can lead to ambiguous results and potentially misdiagnoses. However,
connecting electronics to a biological environment for quantitative monitoring
can be difficult, and so assays which provide electrochemical readouts are at-
tractive as biosensors for their ability to directly transduce biological events into
an electronic signal (68). Electrochemical biosensors require a bioreceptor for
analyte recognition, which will interface with a surface architecture where bio-
logical events take place, and a transducing element (for example, current gener-
ated as a result of the biological event), which is turned into an electronic signal,
and is processed for display (Fig. 1.8).
16 Chapter 1. Introduction
FIGURE 1.8: Elements required for an electrochemical biosen-
sor. A wide range of sensors have be developed through mixing
of different combinations of bioreceptor elemnts and electrical
interfaces. Portability can be achieved through miniaturization of
signal amplification and processing components, such as through
the use of a microprocessor with a smart phone. Image from ref-
erence (68).
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Electrochemical sensors largely fall into three categories for signal transduction:
amperometric, potentiometric, and capacitive (69, 70). In response to a bio-
logical event, amperometric sensors generate a current, potentiometric sensors
accumulate a charge, and capacitive sensors alter conductive properties (71).
Of these, amperometric sensors are the most popular and widespread for use in
commercial devices, if only for the fact that the most well-known electrochem-
ical biosensor is the glucose meter (72). In fact, this device alone accounts for
85% of the world’s biosensor market (73).
Glucose meters rely on the following reaction scheme for electrochemcial detec-
tion (where GOx-FAD+ is glucose oxidase conjugated to a redox cofactor which
acts as an initial electron acceptor):
1. Glucose + GOx – FAD+ −−→ Glucolactone + GOx – FADH2
2. GOx – FADH2 + O2 −−→ GOx – FAD+ + H2O2
Hydrogen peroxide is then oxidized at an electrode, and the flow of electrons is
recorded as a current that is proportional to the amount of glucose in the original
sample:
3. H2O2 −−→ 2 H+ + O2 + 2 e–
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While it has undergone some refinement, this principle for glucose detection has
not changed drastically since it was first described, over 40 years ago (74). While
the ubiquity and utility of the glucose sensor highlights the potential for a next
generation of electrochemcial biosensors, its success has yet to be matched by
any other tool. This detection scheme is based on a redox reaction that is linked
to the oxidation of glucose, limiting its use in the detection of other analytes
(75). For the development of novel electrochemcial biosensors, new detection
strategies must be explored. Currently, the most popular bioreceptor elements
used in electrochemical sensing are enzymes, due to their specificity (76, 77),
like the glucose sensor. Increasingly reported, however, are those that utilize an-
tibodies, whole cells, and nucleic acids (78).
In POC applications, miniaturization is one of the most important features af-
forded by electrochemical detection strategies. Miniaturization opens up the
possibility for multiplexing and portability (79–84). Additionally, the low power
needs of miniaturized devices means that measurements could feasibly be taken
using a smart phone USB port both as a power source and as an analyzer, po-
tentially allowing for epidemiological monitoring by automatically uploading
results to a centralized databank (85).
For example, Lillehoj, et. al. demonstrated a microfluidics-based LOC diagnos-
tic sensor for the detection of malaria biomarkers which was integrated with a
compact mobile phone platform (Fig. 1.9) (86). They developed a microchip-
sized potentiostat, and a phone application with a simple user interface to walk
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users through the detection process, all via the phone’s USB port. Their device
was based on capturing antibodies in a polypyrrole matrix on a simple planar
gold electrode, which limited sensitivity to about 16 ng mL-1. Smartphones are
growing in ubiquity in the developed world, and with the advent of low-cost An-
droid phones, they are poised to become even more common in the developing
world (87, 88). As such, tailoring LOC development towards devices amenable
to smartphone integration is proving an exciting avenue for the future of electro-
chemical diagnostics.
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FIGURE 1.9: A prototype fully integrated LOC for malaria
biomarker detection. This setup incorporated an electrochemi-
cal biosensor with a microfluidic channel system. Detection pa-
rameters (e.g. redox potential) were transmitted from a custom
application via USB to a microcontroller. The microcontroller
transmits detection parameters to a potentiostat module, which
will measure voltage and current signals from the microfluidic
chip. The microcontroller processes these signals and transmits
them back to the phone in real-time. Red arrow points to the
microfluidic sensing device. Image from reference (86).
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FIGURE 1.10: A capture antibody is adorbed onto an electrode,
and captures cholera toxin. A GM1 functionalized liposome
filled with a redox species is tethered to the electrode surface
via a sandwich format, allowing for electrochemical detection of
cholera toxin. Image from reference (90).
1.3 Strategies for sensor functionalization
Electrochemical sensors utilize a variety of recognition elements. For exam-
ple, research into POC cholera sensors has generally sought to exploit the affin-
ity of cholera toxin’s beta subunit for GM1 gangliosides (9, 89). Viswanathan
et. al. used an assay similar to a sandwich ELISA to detect cholera toxin by
binding cholera toxin to the surface of carbon nanotubes via antibody capture
(Fig. 1.10). Toxin was then detected when GM1 functionalized liposomes en-
capsulating potassium ferricyanide bound to the immobilized cholera toxin, and
the potassium ferricyanide was detected by square wave stripping voltammetry
(90). However, while GM1 is a natural receptor for cholera toxin and E. coli
heat-labile enterotoxin, this strategy cannot be employed for other biomarkers.
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1.3.1 Methods of antibody tethering
Antibodies remain a much more attractive bioreceptor element due to both their
specificity and due to their high commercial availability. In fact, antibodies have
been used extensively in traditional diagnostic immunoassays, and so it would
follow that they would be adopted for the use in POC sensor applications as well
(91, 92).
Indeed, a number of electrochemical antibody-based sensing platforms have
been reported for detecting oncogenic biomarkers (93–95). Surface immobi-
lization of antibodies can have severe impacts on their function, however, so
care must be taken in choosing an immobilization technique that preserves the
availability of the antigen binding region. One of the most well known uses of
antibodies in diagnostics is the the ELISA. Adsorption of the capture antibody
to the polystyrene substrate is achieved through hydrophobic and electrostatic
interactions (96). Due to the random nature of this method, microtiter plates for
ELISA must be sufficiently large to overcome the deficiencies caused by sub-
optimally bound antibodies, leading to the need for volumes in the hundreds of
microliters of sensing reagents for detection.
An antibody is comprised of two fragment antigen binding regions (Fab), and
a fragment crystallizable region (Fc). Studies have shown that the activity of
antibodies covalently bound to a solid surface is about half that of soluble an-
tibodies, which is a major hinderance for antibody-based sensor development
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FIGURE 1.11: Antibodies allowed to adsorb onto a bare gold
substrate will do so in a random manner, resulting in diminished
availability of the antigen sensing region for analyte detection.
(97, 98). If allowed to adsorb with no direction, antibodies adopt variable ori-
entations, including tail-on (Fc attached to surface), head-on (Fab attached to
surface), side-on (one Fc and one Fab attached to surface), or flat-on (all frag-
ments attached to surface) (Fig. 1.11) (99). Tail-on is the most desirable due to
the unobstructed availability of the Fab (100–103). Since the Fab is unique from
the Fc in physical structure, isoelectric point and and composition, methods for
oriented antibody attachment to a solid surface have been developed which ex-
ploit their distinction. (104).
The use of bacteria-derived protein A and protein G are particularly attractive for
oriented antibody tethering, as they constrain surface binding to only the Fc re-
gion of the antibody (Fig. 1.12) (105–107). Of the two, protein G shows the most
promise, as protein A has been demonstrated to bind the Fc in a highly reversible
manner, and to also sometimes bind to the Fab and to albumin (104). Using pro-
tein G as an intermediate binding protein not only aids in the orientation of the
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antibody, but also helps to reduce the negative effects of steric hindrance that
may result from the proximity of attached antibodies to each other (108).
In biosensor development, conductive polymers are also gaining popularity as
a means of tethering antibodies to electrode surfaces. This method is facile,
cost-effective and stable; all useful features towards POC diagnostics develop-
ment (109). Conducting polymers are well-suited to integration with a redox-
based detection mechanisms because alternating single and double bonds in the
polymer allow it to transfer charge efficiently (110). Polypyrrole specifically
has emerged as a frequently-used polymer in biosensing applications, due to the
gentle conditions of its one-step electropolymerization (110). Polypyrroles have
been used in amperometric biosensors due to the tight adherence of the poly-
mer to the working electrode (111), the potential for adding functional groups
that allow for protein tethering, the stability at ambient conditions (112), and the
ability to polymerize in neutral aqueous solutions (113). Much work has been
directed towards the entrapment of recognition elements within the polymeric
matrix, particularly for the enzyme glucose oxidase. Fouldes and Lowe demon-
strated almost 30 years ago that GOx, which is negatively charged at pH 7.0, can
be easily ionically incorporated into a polypyrrole matrix, which is net positive
charged at the same pH (114). Their glucose sensor was limited, however, due
to leeching of the enzyme out of the matrix, and due to polymer degradation in
the presence of H2O2. Such a method of immobilization also leaves open the
possibility for biomolecules to be denatured (102). An ideally suited biosensor
would allow biomolecules to remain correctly oriented while maintaining their
1.3. Strategies for sensor functionalization 25
FIGURE 1.12: Oriented antibody binding can be achieved by
using protein G as an intermediate. Image from reference (105).
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native state.
For this reason, functional groups have been added to pyrrole polymers that al-
low for covalent bonding (via terminal reactive groups such as COOH and NH2)
(115, 116) or electrostatic interaction with the polymer surface, rather than ma-
trix entrapment (117, 118). Electrostatic binding requires the least amount of
work, but is limited by sensitivity to solution pH, which can cause the release of
the protein from the polymer. However, Ouerghi, et. al. demonstrated that this
method can be used for antibody biofunctionalization with a decent amount of
control over antibody orientation. They reported the use of a polypyrrole with a
terminal CN group, which electrostatically interacted with OH groups on the Fc
region of their antibody (102).
Um, et. al. took this protocol even further to achieve better antibody orientation.
They utilized a cyclic voltammetry (CV) scheme in order to attract negatively
charged antibodies to the polymer surface at times when the surface was posi-
tively charged (103). This allowed the antibody to be tethered in one direction,
leaving more antigen-binding regions available for sensing, as demonstrated by
fluorescence imaging.
The mechanism of deposition of a polypyrrole film onto an electrode surface
remains somewhat controversial due to the difficulty in following in situ what
is happening at the electrode/solution interface, but it is generally accepted that
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it begins by the anodic oxidation of the monomer in the presence of an elec-
trolyte to create a cation free radical (119, 120). Pyrrole can be electrodeposited
potentiostatically (constant voltage), galvanostatically (constant current), or po-
tentiodynamically (potential scans) (121).
1.4 Nanoarchitectures for sensitive electrochemical
detection
An electrochemical reaction is detectable only in close proximity to the electrode
surface. As such, the choice of electrode architecture can have huge implications
in the sensitivity of electrochemical detection (68). Nanotechnology is a field
that deals with the study of structures usually 1 to 100 nm in size, where mate-
rials exhibit unique properties (122–124). Nanoscale sensors may be desirable
because their increased surface-area-to-volume ratio means that more atoms are
available at the surface of the sensor for chemical reactions and signal detection
(125). Sensors based on nanoarchitectures hold the potential to enable sensitive,
specific, portable and low-cost diagnostics.
The field of nanotechnology is driven by the development of novel surface nanoar-
chitectures in the search for more sensitive devices. As stated previously, surface
architectures exhibit unique characteristics at the nanoscale. This was demon-
strated by a silicon nanowire array developed by Elfstrom, et. al., who showed
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FIGURE 1.13: On a nanocoaxial array, decreasing the size of the
annulus gap between the working and counter electrodes resulted
in increasing sensitivity to the redox species ferrocenecarboxylic
acid. Image adapted from reference (127).
that nanowires >150 nm in width were not sensitive to pH changes in a buffer,
while smaller ones were (126). This was further demonstrated by Rizal et.
al., who showed that increasingly smaller nanometer scale distances between
a nanocoaxial working and counter electrode resulted in greater and greater sen-
sitvity to a redox species (Fig. 1.13) (127).
AuNPs are a prominent architecture for integration in electrochemical sensors,
and protocols exist that allow for control over their size, dispersion, morphology
and surface chemistry, providing for a broad range of sensor setups and detection
methods (128). Of particular interest in the field of biosensing is the amenability
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of AuNPs to biofunctionalization, specificically by antibodies. Antibody bio-
functionalization of AuNPs was first reported in 1971, and so there have been
over 40 years of development towards using these functionalized nanoparticles
in numerous applications (129, 130).
Antibody functionalization of AuNPs offers two major advantages in a sens-
ing capacity: they enhance electrochemical signal transduction, and increase the
overall surface area onto which antibodies can be stably bound, thus increasing
the number of antigen-antibody recognition events that can be detected. Elec-
trochemical biosensors based on antibody/AuNP tethering have been reported
for the amperometric and potentiomtric detection of hepatitis B surface antigens
(131) and for the potentiometric detection of diptheria (132, 133). Additionally,
Chen et. al. demonstrated the utility of AuNPs as the actual electrochemical
label for detection, by measuring the number of AuCl4- anions generated upon
oxidation of the AuNP (Fig. 1.14) (134).
Nanowire arrays are another class of nanostructure used extensively in elec-
trochemcial sensing, which have been reported using a variety of materials. For
example, Si nanowires were fabricated by Patolsky, et.al., which were capable
of the electrical detection of a single virus (135), while Yin, et. al. incorporated
silver nanoparticles on Si nanowires for the detection of H2O2 (136). In the con-
text of biosensing and disease diagnosis, Zheng, et. al. demonstrated highly
sensitive and multiplexed detection of prostate specific antigen (PSA) using a Si
nanowire array (137). This setup detected down to an impressive 0.9 pg mL-1 of
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FIGURE 1.14: A biosensor based on AuNP/antibody tethering.
In this example, a sandwich style assay is employed for detec-
tion. The AuNP is oxidized, and the resultant AuCl4- anions are
measured at the electrode surface. Image from reference (134).
PSA in a label-free manner, compared to 3 pg mL-1 for a standard optical ELISA.
Electrochemical sensors based on nanostructured electrodes, and integrated with
microfluidic fluid handling systems represent one of the most promising combi-
nations for true A.S.S.U.R.E.D. diagnostics. But while the potential is there, the
actual application is essentially nonexistent. Use of such devices seems largely
relegated to the laboratory, with few systems seeing any sort of commercial in-
terest, especially so for the detection of infectious diseases of poverty. As such,
the field remains open to the contribution of novel nanoscale surface architec-
tures, and to the development and refinement of assays with which to integrate
them.
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1.5 Aims of study
This research detailed in this dissertation involves the exploration of different
methods of surface biofunctionalization on two different nanostructured sensing
platforms: gold dendrites and the extended core nanocoax (ECC). After func-
tionalization, the sensors were evaluated for proof-of-concept utility as electro-
chemical LOC diagnostic sensors. This work was completed in collaboration
with the physics laboratory of Dr. Michael J. Naughton.
The dendritic architecture has been previously characterized and utilized in CO2
electrolysis. Here, the structure was given biological utility through the elec-
trodeposition of a conductive polypyrrole film. Capture antibody was electro-
statically tethered to this film, creating a biofunctionalized substrate for cholera
detection via electrochemical ELISA. Its performance was compared to a planar
LOC and a standard optical ELISA.
The novel ECC architecture was investigated, and its fabrication was optimized.
Electrochemcial performance of the ECC was evaluated relative to a standard
set by a previous nanocoaxial iteration (which lacked an extended core). ECCs
were then biofunctionalized using protein G to tether capture antibody. An elec-
trochemical ELISA was performed on-chip, and the performance was compared
to a standard optical ELISA.
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Cholera toxin subunit B was used in this study due to its clinical relevance, sta-
bility, safety and availability. However, it is conceivable that the procedures





2.1 Chemicals and Reagents
Cholera toxin subunit B (CTX), ferrocenecarboxylic acid (FCA), ethanol, ethylene-
diaminetetraacetic acid (EDTA), poly-(2-cyano-ethyl)pyrrole (PCEPy), sodium
perchlorate (NaClO4), HEPES, glycerol and H2SO4 were purchased from Sigma-
Aldrich (St. Louis, MO). Anti-cholera toxin subunit B polyclonal and mon-
oclonal antibodies and alkaline phosphatase (ALP) conjugated antibody were
obtained from Abnova (Taipei, Taiwan). p-Aminophenylphosphate (pAPP) was
acquired from Gold Biotechnology, Inc. (St. Louis, MO). The BluePhos phos-
phatase substrate system was purchased from KPL (Gaithersburg, MD). Hydro-
gen tetrachloroaurate(III) trihydrate (HAuCl4), bovine serum albumin (BSA),
Tween-20, phosphate buffered saline (PBS), and Tris base were obtained from
Fisher Scientific (Pittsburgh, PA). Protein G was purchased from Protein Mods
(Madison, WI). The Innovacoat ® Gold nanoparticle 40 nm conjugation kit was
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obtained from Novus Biologicals (Littleton, CO).
Shipley 1813 photoresist, Mf-319 developer, Microposit 1165, LOR-3B resist,
and SU-8 were purchased from MicroChem Corp. (Westborough, MA). Transetch-
N and Cr 1020 etchants were purchased from the Transene Company, Inc. (Dan-
vers, MA). EponTM resin 828 and Epikure 3140 curing agent were obtained from
Miller-Stephenson Chemical Co. Inc. (Danbury, CT). Hydrogen peroxide (27%)
and ammonium hydroxide (28%) were procured from Alfa Aesar (Ward Hill,
MA).
2.2 Fabrication of dendritic arrays
Dendritic arrays were fabricated with the guidance of Dr. Nathan T. Nesbitt in
collaboration with the laboratory of Dr. Michael J. Naughton as described below.
2.2.1 Preparation of planar substrates
Planar silicon wafers (University Wafers, Boston, MA) were cleaned via son-
icaton in acetone for 10 minutes. Using an AJA sputtering system (AJA In-
ternational, Inc., Scituate, MA), a 10 nm adhesion layer of Ti was deposited,
followed by ~120 nm of Au. Samples were diced into 16x30 mm2 chips using a
DAD3220 dicing saw (Disco, USA). Samples were cleaned for 10 minutes prior
to well attachment, using a 1:1:5 mixture of hydrogen peroxide (27%), ammo-
nium hydroxide (28%) and diH2O heated to 80°C, in a procedure called RCA
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cleaning (138). Chips were then rinsed thoroughly with diH2O and 200 proof
ethanol, and allowed to dry. If chips were to be used as planar controls, wells
were attached using the EponTM resin 828 and Epikure 3140 two part epoxy sys-
tem (139). Plastic wells were made from pipette tips (Denville, USA) with a
base area of ~19 mm2, which were cut to a height of ~1 cm, with the manufac-
tured end attached to the substrate surface to ensure a tight seal. Substrates were
placed into a 50°C oven to prevent epoxy from spreading into the sensing region,
and allowed to cure overnight.
2.2.2 Directed electrochemical nanowire assembly (DENA)
Gold electrodeposition onto Ti/Au (10 nm/120 nm) coated chips was carried out
with a waveform generator (Agilent 33600A Series) using a two-electrode setup
(Fig. 2.1). The waveform was monitored with an oscilloscope (Agilent MSO-X
3024A) during electrochemical deposition, using a 10:1 passive probe (Agilent
N2863B) to minimize the oscilloscope’s disturbance of the waveform. The Au
flat film served as the working electrode (WE), and a platinum coiled wire as the
counter electrode (CE). A square waveform with frequency of 30 MHz, peak-
to-peak amplitude of 10 V, offset of -2 V, and duty cycle of 50% was applied
for 20 min in a solution of 30 mM HAuCl4. For dendritic samples, an epoxy-
free removable and reusable well system was utilized, to prevent the wicking
properties of the dendrites pulling epoxy into the functional sensor area. The
reusable well system (Fig. 2.2) creates 7 water-tight sensing arrays, in order to
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minimize the effects of dendritic growth differences that are observed chip-to-
chip.
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FIGURE 2.1: The two electrode setup for DENA. A platinum coil
acts as a counter electrode, and the gold surface of the chip acts
as the working electrode.
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FIGURE 2.2: A removable well system is used to divide each
chip into 7 sensing regions. An external CE and RE are inserted
into the well of interest, and the chip is hooked up to a potentio-
stat for electrochemical measurements.
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2.3 Fabrication of extended core nanocoaxial ar-
rays
Fabrication of extended core nanocoaxial arrays was generously carried out by
Luke D’Imperio in collaboration with the laboratory of Dr. Michael J. Naughton
as described below.
2.3.1 Preparation of pillar substrates
Silicon pillar chips 16x30 mm2 in size were prepared for metal deposition. A
3:1:H2SO4:H2O2 piranha cleaning mixture was prepared (140). Briefly, H2SO4
was heated to 150°C, and H2O2 was added slowly. The Si wafer was submerged
in the mixture, and after 20 min it was thoroughly rinsed with diH2O, and dried
with N2 air.
2.3.2 Photolithography and metal deposition
Before beginning the first round of photolithographic patterning, the Si wafer
was plasma cleaned. After, LOR-3B resist was added using a spinner set to
ramp to 500 rpm for 8 s, followed by 1,000 rpm for 30 s. The chip was then
baked on a hot plate for 5 min at 150°C. Next, Shipley 1813 photoresist was
spun on with a ramp of 500 rpm for 8 s followed by 2,000 rpm for 45 s, followed
by 5 s at 3,000 rpm. The sample was baked a further 2 min at 110°C, and then
exposed for 7.5 s using a Suss mask aligner (SUSS Microtec, Germany). After
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exposure, the sample was developed with MF-219 for 50 s, then immediately
rinsed with diH2O and dried with N2 air. This leaves behind open areas where
the first metals should be deposited.
After initial patterning, Ti and Au were sputtered on to a thickness of 10 nm and
110 nm, respectively. Microposit 1165 solution heated to 75°C was then used to
lift off the Ti/Au from any areas where photoresist remained over a span of 2 h,
leaving behind gold pads and leads.
Atomic layer deposition using a Cambridge ALD machine (Cambridge Nan-
oTech, Waltham, MA) was used to deposit 200 nm of alumina (Al2O3). After,
an etch-layer mask was applied, and the same photolithographic steps as detailed
above were followed. Chips were submerged in Transetch-N for a minimum of
10 h to open up macropads for final metal deposition. After etching, the sample
is again washed thoroughly with diH2O and dried with N2 air.
Finally, chromium was sputtered on using the AJA system. Cr is deposited to a
thickness of 110 nm, and a liftoff process is followed as previously described.
2.3.3 Formation of extended core
Shipley 1813 was spun on at 500 rpm for 5 s, then 1000 rpm for 45 s. The
samples were soft baked at 110°C for 3 min following photoresist application.
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The sample was exposed on the Suss mask aligner, without any mask, for 1.2
s. The sample was developed in MF-319 for no more than 30 s to expose the
top of the Cr layer (Fig. 2.3a). The Cr layer was then etched away using a Cr
specific etchant, Cr 1020, for 60-70 s at room temperature. The sample was
rinsed with diH2O and dried with N2 air, then imaged by scanning electron mi-
croscopy (SEM) at a 30° tilt to ensure that the Al2O3 layer is exposed (Fig. 2.3b).
Once the Cr layer was confirmed to be etched sufficiently, Transetch-N was used
to etch away the Al2O3 layer for about 15-20h (Fig. 2.3c).
Finally, the Cr layer is again etched to the desired height, creating an extended
gold core. Remaining photoresist is removed with either Microposit 1165 solu-
tion, or acetone. The chip is finally rinsed and washed diH2O and dried with N2
air.
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FIGURE 2.3: The extended core of the ECC is fabricated using
a series of etching steps. (a) After final deposition of Cr, a layer
of photoresist (PR) is added and briefly exposed. Subsequent
development uncovers the top of the Cr layer. (b) The Cr layer is
etched down to reveal the alumina (Al2O3) dielectric layer. This
was then also etched (c) to reveal the gold core. A final Cr etching
step completes the ECC architecture. (Images courtesy of Luke
D’Imperio)
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2.4 Characterization of nanostructures
2.4.1 Scanning electron microscopy
All nanostructures were imaged by SEM for appropriate dendritic growth and
correct extended core formation, respectively. That is, dendrites should be grown
relatively homogeneously over the surface of the electrode, and extended cores
should be about 200 nm above the shield. SEM images of ECCs during and post
fabrication, as well as all gold nanoparticle images were taken using a JEOL
JSM-7001F SEM. SEM images of dendrite arrays were taken using a JEOL
JCM-6000 NeoScope benchtop SEM.
Proof-of-concept of the amenability toward biofunctionalization of both den-
dritic and ECC structures was evaluated via SEM using a gold nanoparticle con-
jugation kit. Anti-mouse IgG/alkaline phosphatase, which acts the final antibody
in the ELISA protocol, was conjugated to a 40 nm gold nanoparticle using the
kit.
Feasibility of antibody functionalization of ECCs was evaluated using a Protein
G monolayer. Thiolated protein G was diluted to 1 mg mL-1 in tris buffered
saline (TBS), and incubated on chip surfaces for 2 h at room temperature. After
rinsing thoroughly 3x in TBST (0.05% Tween-20, 50 mM Tris, 150 mM NaCl,
pH 7.4), the anti-mouse IgG, which was tagged with a 40 nm gold nanoparticle,
was added to the chips for 1 h at room temperature. Chips were washed 3x in
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TBST and allowed to air dry for SEM visualization.
Dendrites were evaluated for the success of antibody tethering to the PCEPy film.
The same AuNP-tagged antibody described above was utilized, with the PCEPy
film taking the place of the protein G layer. A full ELISA was performed on
the chip, up to the application of the tertiary antibody. Chips were then removed
from their housings and washed thoroughly in TBS, then allowed to dry for SEM
visualization.
2.4.2 Resistivity Measurements
ECC arrays were first tested for electrical integrity using a 610B Electrome-
ter (Kiethley Instruments, Cleavland, OH). Resistance between the working and
counter electrodes were measured, and any array with a resistance less than 106
Ω was considered to be shorted, and not used.
2.4.3 Ferrocenecarboxylic acid redox sensitivity assay
Sensing capabilities of both ECCs and dendrites were appraised using the redox
species ferrocenecarboxylic acid (FCA). Differential pulse voltammetry (DPV)
was used to oxidize 1 mM FCA in phosphate buffered saline (PBS), pH 7.4.
The potential range was 0 mV to 500 mV (in order to encompass FCA’s redox
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potential at 300 mV), the potential step was 2 mV, the pulse amplitude was 50
mV, the pulse width was 50 ms, the pulse sample period was 100 ms, and the
equilibrium time was 10 s.
2.4.4 Dendrite surface area assessment
To assess the increase in dendritic surface area over a planar control, cyclic
voltammetry was performed to sweep across the reduction and oxidation poten-
tials of Au (141). Briefly, the working electrode was the Au sample, the reference
electrode was Ag/AgCl in saturated KCl solution, and the counter electrode was
a Pt wire spiral. A tape mask exposed a geometric surface area of 2 cm2 of the Au
working electrode to the electrolyte. All three electrodes were immersed in 500




Electrochemical readout on dendritic sensors was performed using a three-electrode
system on a Reference 1000 potentiostat (Gamry Instruments, Warminster, PA).
The gold surface of the chip functioned as the working electrode (WE). External
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Ag/AgCl and Pt wires served as the reference electrode (RE) and counter elec-
trode (CE), respectively (141). DPV was used as the method of electrochemical
analysis for its suppression of background signal (142, 143).
2.5.2 Extended core coax
Electrochemical readout on the ECC arrays was identical to the dendritic arrays,
with the exception that the outer Cr shield of the nanocoax served as the counter
electrode. An external Ag/AgCl wire served as the RE. DPV was again used as
the method of electrochemical analysis.
2.6 Substrate biofunctionalization
2.6.1 Conductive polymer functionalization
Conductive polymer biofunctionalization was carried out in a 3-electrode sys-
tem: the gold chip surface served as the WE, an Ag/AgCl wire as the RE, and
a Pt wire as the CE. A poly(2-cyano-ethyl)pyrrole (PCEPy) film was formed
using 10 mM 2-cyano-ethylpyrrole in 0.1 M NaClO4 (acting as an electrolyte)
(103). PCEPy was chosen as an antibody tethering substrate for dendritic arrays
because it resulted in minimal nonspecific antibody binding.
The pyrrole monomer was electrooxidized with a chronopotentiometric scan at
800 mV for 100 s (144). To confirm the generation of a PCEPy coated dendrite
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chip, the electrode was washed thoroughly in diH2O, and an aqueous NaClO4
solution containing no monomer was applied. DPV was performed in a range of
0 to 700 mV. A peak around 400 mV is in good agreement with the oxidation
potential of PCEPy (119). Primary capture antibody was then incubated on the
polymer-coated substrate for 48 h to allow for sufficient electrostatic interaction.
2.6.2 Protein G biofunctionalization
Protein G biofunctionalization was carried out using a thiolated protein G diluted
to 1 mg mL-1 in TBS (145). Cleaned substrates were incubated with protein G
for 2 h at room temperature with rocking. Chips were then rinsed thoroughly
3x in TBST, after which primary capture antibody was incubated on the chip
surface for 48 h, allowing the antibody to be tethered by its nonantigenic region
to the protein G.
2.7 Enzyme-linked immunosorbant assay (ELISA)
2.7.1 On-chip electrochemical ELISA
Modified electrodes (PCEPy or protein G) were incubated for 48 hours at 4°C
with a primary anti-cholera toxin antibody diluted to 1 mg ml-1 in 10 mM HEPES.
After incubation, electrodes were rinsed 3x with TBST, and blocked for 1 hour
at room temperature using 5% bovine serum albumin (BSA) and 5% glycerol in
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TBST to prevent nonspecific binding to the well or, for PCEPy modified elec-
trodes, to any remaining free cyano sites.
Several concentrations of cholera toxin beta subunit antigen (CTX) were pre-
pared in 2% BSA/TBST, ranging from 0.5 ng mL-1 to 500 ng mL-1, and were
added to the chip surface and incubated for 1 h at room temperature. The chip
was again rinsed 3x with TBST. A secondary anti-cholera toxin antibody was
diluted to 50 ng mL-1 in 2% BSA/TBST and was added to the chip surface for 1
h at room temperature, after which the surface was washed 3x with TBST.
A final tertiary antibody, anti-mouse IgG conjugated to alkaline phosphatase was
added at a concentration of 2.7 µg mL-1 for 1 h at room temperature. The chip
was washed 6x with TBST. Finally, 1 mM p-aminophenylphosphate (pAPP) was
added to the chip surface for 30 min in the dark. The reaction was stopped with
20 µL of 50 mM EDTA in TBS. The 4-aminophenol (4-AP) generated was ox-
idized directly on the chip surface via DPV in a potential range of -300 mV to
200 mV, with a potential step of 2mV, a pulse amplitude of 50 mV, a pulse width
of 50 ms, a sample period of 100 ms, and an equilibrium time of 10 s (142).
The chemical reactions taking place are the following:
1. H2O + pAPP −−→ 4 AP + HPO42 –
2.7. Enzyme-linked immunosorbant assay (ELISA) 49
2. 4 AP −−→ 4 QI + 2 H+ + 2 e–
2.7.2 Off-chip electrochemical ELISA
Off-chip electrochemcial ELISA assessments were carried out similarly to on-
chip, with the following modifications. A 96-well microtiter plate was used in
place of the gold chip surface for tethering of the primary capture antibody. In or-
der to facilitate binding to the plastic microtiter plate, the primary antibody was
diluted in 0.1 M NaHCO3 for only 2 h. The plate was then blocked overnight
in 5% BSA in TBST. All subsequent reagent application (cholera toxin, sec-
ondary antibody, tertiary antibody, and enzyme substrate) and wash steps were
performed in the microtiter plate as previously described. The final redox prod-
uct, 4-AP, was applied to the surface of the nanostructure being examined for
electrochemical measurement. DPV settings were as previously described.
2.7.3 Conventional optical ELISA
Optical ELISAs were performed identically to the off-chip ELISA, with the ex-
ception that for the last step, the BluePhos phosphatase system took the place of
pAPP as the reaction substrate. Absorbance was measured spectroscopically at
λ=600nm on a SpectraMax M5 (Molecular Devices, Sunnyvale, CA).
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2.8 Data analysis
Titrations of cholera toxin were analyzed by overlapping DVP signals. Any
nonspecific peaks were subtracted from all data points. Raw DPV signals were
also subtracted to zero at -200 mV to ensure that observed peak currents were
accurate (Fig. 2.4). Baselining to zero allows for true comparison of different
concentrations of CTX when assessing the performance of devices. Peak current
(Ip) for each signal and plotted against CTX concentration to determine detection
limits and range of detection.
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FIGURE 2.4: (a) Raw DPV signals for a titration of alkaline
phosphatase (ALP) antibody. (b) DPV signals baselined at -200






The importance of POC diagnostic technologies has been highlighted by sev-
eral recent high-profile infectious disease outbreaks. In 2017, Yemen’s cholera
epidemic became one of the largest and most rapidly spreading in modern his-
tory (146). While several factors have contributed to the severity of this and
many other outbreaks, such as Ebola, a lack of rapid diagnostic tools and epi-
demiological monitoring cannot be ignored, as these are critical in controlling
the spread of disease within human populations. Fecal culturing remains the
benchmark of cholera diagnosis, but this method is a process which is both time-
consuming, requiring up to 2 full days for cultures to develop, and necessitates
clinical laboratory infrastructure (14). A more portable and rapid diagnostic tool
exists, the Crystal VC Dipstick, but it suffers from a relatively high rate of false
positives (21). There remains an unmet need for portable, cost effective detec-
tion methods, which exhibit specificity and sensitivity at the POC. Robust POC
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FIGURE 3.1
technologies can facilitate better prevention and earlier response, enabling ac-
curate diagnosis and proper treatment, and thus improved patient prognosis and
limited economic impact (147). Here, we combined directed electrochemical
nanowire assembly (DENA) with a conductive polypyrrole polymer (poly-(2-
cyano-ethyl)pyrrole (PCEPy)), which facilitates biofunctionalization of dendrite
surfaces, in order to fabricate proof-of-concept electrochemical sensors for the
detection of CTX (Figure 3.1).
3.1. Introduction 55
FIGURE 3.1: A schematic overview of the dendrite-based lab-on-
a-chip ELISA. (a) Dendrites grown on a planar gold substrate.
(b) Dendrites coated in a film of poly-(2-cyano-ethyl)pyrrole
(PCEPy). (c) Primary ELISA antibody tethered to PCEPy coated
dendrites via electrostatic interactions. Cholera toxin (CTX),
secondary anti-CTX antibody, and tertiary antibody are added,
with wash steps between each. (d) Alkaline phosphatase (ALP)
conjugated to the tertiary antibody reacts with the substrate p-
aminophenylphosphate (pAPP) to form 4-aminophenol (4-AP),
which (e) redoxes at -100 mV. This redox peak is proportional to
the amount of CTX in the sample.
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3.1.1 Metallic dendrites as biosensor substrates
Metallic dendrites are an important class of nanostructures for LOC develop-
ment. They consist of branching, tree-like projections of crystals of a single
metal or alloy. Directed electrochemical nanowire assembly (DENA) is a one-
step, high growth rate technique to produce oriented, single-crystal metallic den-
drites from an electrode surface at standard atmospheric and temperature condi-
tions (148). This is accomplished by electrodeposition, where alternating elec-
tric field in the presence of a salt solution induces the crystallization of dendrites
onto an electrode (149). The direction of dendrite growth is guided by the elec-
tric field (150). The dendritic structures form because of the diffusion limits of
electrodeposition. That is, during deposition, only solute that is close to the sur-
face is crystallized. This creates a diffusion boundary layer, as solute near the
surface is used up, and new solute must diffuse from the bulk solution to the
surface (141). Protrusions of the crystal are able to reach into this boundary and
receive diffusing solute at a faster rate, creating dendrite structures (151).
DENA was first performed for the growth of palladium nanowires (152), but has
since been used for the fabrication of structures composed of various metallic
crystals, such as platinum, gold and silver (153–155). Gold was chosen in this
study due to its biocompatibility and relative inertness.
Dendrites have found use as a substrate for numerous applications, including
catalysis (156), chemical sensing (155), and electrochemical sensing (157). This
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is due, in part, to an increase in the effective surface area that may afford higher
detection sensitivity (154). This can be as a result of two features of the sen-
sor: first, a greater number of the biomolecules used as recognition elements for
specific antigens can be tethered to the electrode surface compared to a planar
substrate of the same footprint area, and second, the increase in surface area
means that more biological events are happening in proximity to the working
electrode.
On this latter point, the direct positioning of both capture and detection reagents
on the surface of an electrode has been exploited to create a highly sensitive di-
agnostic device for human immunodeficiency virus that was capable of detecting
1 ng mL-1 of HIV-1 and HIV-2 (158). We speculated that a sensing device based
on a dendritic architecture may be capable of highly sensitive biomolecule de-
tection due to both the increased number of recognition elements, as well as the
localization of those elements in proximity to the electrode surface. The ability
to maintain high sensitivity on a miniaturized electrode also means that a metal-
lic dendrite-based sensor should require a smaller quantity of sensing reagents,
decreasing the cost per assay and furthering the goal of A.S.S.U.R.E.D. diagnos-
tics.
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3.2 Aim of Study
Here, we used DENA to generate dendritic gold electrodes (Fig. 3.2), which
were then modified with a conductive polypyrrole polymer PCEPy. In order
to fabricate electrochemical sensors for the detection of CTX as a proof-of-
concept LOC biosensor, anti-CTX antibodies were electrostatically tethered to
the poylpyrrole film. An ELISA was then performed on the chip surface, and the
presence of CTX antigen was determined via DPV of the redox product 4-AP.
Electrochemical performance of these dendritic sensors was evaluated against a
planar gold sensor and a standard optical ELISA to determine its potential for
development as a POC diagnostic device.
3.3 Dendrite growth and characterization
Dendritic arrays were fabricated using DENA (Fig. 3.3). A Si wafter was first
coated with an adhesion layer of Ti, then ~120 nm of Au. This Au film substrate
served as the WE, which was situated across from the platinum wire that served
as the CE. These were both submerged in a 30 mM solution of tetrachloroauric
acid (HAuCl4). A square waveform with a frequency of 30 MHz, a peak-to-peak
amplitude of 10 V, an offset of -2 V, and a duty cycle of 50% was applied for
20 min. A comparison of a planar gold chip before and after dendrite growth is
shown in Fig. 3.4 , in order to demonstrate the drastic morphological difference
between both architectures. Variations in several parameters, including voltage
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FIGURE 3.2
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FIGURE 3.2: SEM of representative dendrite growth on a flat Au
film. Dendrites show relatively consistent growth over large parts
of the surface. That is, there are not large swaths of dendrite-free
substrate, and likewise there are not regions with significantly
larger or differently shaped dendrites. Images are shown at 900x
(left) and 130X (right) for context.
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offset (Fig. 3.5), solution concentration and peak-to-peak amplitude, can greatly
impact the morphology of resultant dendrites. Previous work by collaborators
has thoroughly characterized the effects of dendrite growth parameters, and so
this study did not explore these further (141).
Growth parameters for this study were chosen based on consistency in dendrite
formation over the area of the chip, and robustness of the crystals (i.e. dendrite
crystals do not break off the base substrate with handling or with application of
fluids). Immediate confirmation of electrodeposition can be initially optically
confirmed, as the dendrite region will appear brown and rust-like compared to
the bare gold surface. SEM was used to confirm proper fabrication, which was
defined as uniform growth of crystals over the sensor surface, inasmuch can be
achieved from a random process like crystallization. It should be noted, however,
that dendrite growth closer to the bottom edge of submerged chips grew signif-
icantly more thin, branching dendrites, which can be explained by the presence
of a corner which concentrates electric fields (Fig. 3.6). Exploiting this phe-
nomenon could conceivably be achieved by using a pillared gold array as the
substrate as opposed to a flat Au film. However, for the purposes of simplicity
in this study, this extra step was not explored.
Individual dendrites demonstrate extensive branched structures that range from
tens to hundreds of microns in length, increasing the surface area of the ar-
ray. The increase in surface area over a planar control was measured by cyclic
voltammetry (Fig 3.7a). Analysis was performed on three separate dendrite
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chips, all grown following the same parameters described above. Analysis showed
the effective dendrite surface area to be approximately 18 times greater than a
planar chip of the same base area (Fig. 3.7b). However, the dendrites exhibited
more variation in their peak current even though they were produced identically
than was observed on planar electrodes. This is likely due to the hierarchical
nature of dendrite formation, caused by the mass transport limitations in the
crystallization, discussed above (141). This means that crystallization happens
faster at protrusions that extend into the bulk liquid. Since this is a random pro-
cess, it can result in differing chip surfaces.
As a baseline assessment of electrical functionality, dendrites were next used to
measure the redox of ferrocenecarboxylic acid (FCA). This is done to ensure
chips are functional and consistent, i.e. little-to-no drop in peak current should
be observed from one run to the next on the same sensing region (Fig 3.8). Chips
were set up in the three-electrode system previously described. A 1 mM solution
of FCA was applied to the chip along with CE and RE wires. Measurements
were performed with DPV, chosen as the method for electrochemical analysis
due to its suppression of background current and high sensitivity (159). DPV
was performed in the potential range of 0-500 mV, in order to encompass FCA’s
oxidation peak which occurs at ~300 mV.
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FIGURE 3.3
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FIGURE 3.3: Experimental setup for dendritic growth on a planar
gold substrate (WE) (right) with a parallel CE (Pt) (left). Dendrite
growth is visible as a rust-like area on portions of the WE that
are submerged in the HAuCl4. Inset illustrates an example of
correctly formed dendrites.
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FIGURE 3.4
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FIGURE 3.4: SEMs taken at 300 and 220x of a planar chip before
and after DENA demonstrate the change in surface architecture.
Planar chip was imaged on an edge to aid in visualization, as the
planar surface lacks any appreciable features otherwise. Defects
on the planar chip are a result of the dicing process.
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FIGURE 3.5
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FIGURE 3.5: SEMs of the effects of varying just one param-
eter (voltage offset) on the resulting shape of dendrite crystals.
Morphology can also be controlled by the length of deposition,
solution concentration, and peak-to-peak amplitude, but these pa-
rameters were not explored in this study. An offset of -2 V was
chosen for use in chips for biofunctionalization.
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FIGURE 3.6
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FIGURE 3.6: SEMs magnified at (a) 22x and (b) 1300x show that
the concentration of electric fields at edges can impact the growth
of dendrites. A white circle encloses the region of the chip of
interest. Here, the bottom edge of the Au film experienced the
growth of delicate and thinly branched crystals.
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FIGURE 3.7
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FIGURE 3.7: Cyclic voltammetry performed on dendrites and
planar (flat film) gold to determine differences in surface area.
(a) Overlaid CVs of 500 mM sulfuric acid on each nanostructure
show the dendrite array has a significantly higher surface area rel-
ative to the planar electrode. X axis represents DV bias potential;
Y axis represents current. (b) The average relative surface area of
3 of the dendrite chips was calculated by normalizing relative to
results from 3 planar electrodes. Scale bars represent the standard
deviation.
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FIGURE 3.8
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FIGURE 3.8: Raw FCA oxidation peaks for 6 trials on one den-
dritic sensing array. Average represents the average peak current
achieved in each run, and error is the standard deviation of this
peak current.
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3.4 Dendrite surface modification
We first attempted to functionalize dendrites with a thiolated protein G, which
specifically binds the Fc region of antibodies. Due to the affinity of antibod-
ies to bind to gold, extensive blocking methods proved insufficient to prevent
non-specific binding to either the gold electrode or free protein G sites, result-
ing in large 4-AP redox peaks that were unrelated to analyte concentration (in
the µA range, dwarfing true nA sized specific peak currents) (Fig. 3.9). Block-
ing strategies included the use of BSA, milk, fetal bovine serum (FBS), and a
high concentration of nonspecific IgG. None were successful in reliably block-
ing the gold electrode from binding secondary and tertiary ELISA antibodies.
Ultimately, it was speculated that the amount of gold surface area in use was too
great to reliably and consistently block, and the strategy of covering the WE with
a layer of polymer was conceived.
A galvanostatic method of deposition was first compared against a potentiostatic
one on a planar electrode to determine the best method for PCEPy electrogen-
eration. The galvanostatic deposition was undertaken at 0.25 mA/cm2 for 2 min
in a solution of 10 mM 2-cyano-ethylpyrrole in 0.1 M NaClO4 acting as an elec-
trolyte. For the potentiostatic method, a controlled potential of 800 mV was
applied for 100-120 s in the same monomer solution. Generation of a PCEPy
film can be confirmed optically, as a change in the electrode surface to a darker
brown color (Fig. 3.10a). However, in order to not disturb the electrode surface
after PCEPy film generation, wells were not removed until each assay was fully
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complete. To assess the success of electrogeneration before biofunctionalization,
a DPV of a monomer-free solution of NaClO4 was performed. A peak around
-400 mV is indicative of a film of PCEPy. Arrays that did not produce this
peak were subjected to a second round of PCEPy deposition. PCEPy oxidation
measurements taken on 3 different dendrite chips show that despite variations in
dendrite crystal growth, a similar amount of PCEPy is deposited (Fig. 3.10b).
While the galvanostatic method initially seemed more promising, due to well-
defined PCEPy oxidation peaks (Fig. 3.11a), this polymer film did not appear
to function well for the on-chip ELISA protocol, as evidenced by small, mis-
shapen 4-AP oxidation peaks (Fig. 3.11b). In contrast, the potentiostatic method,
while demonstrating broader, less-defined PCEPy oxidation peaks (3.11c), gave
much larger and more well defined 4-AP oxidation peaks after an on-chip ELISA
(3.11d).
In order to confirm that antibodies tethered to the gold surface were responsible
for 4-AP oxidation peaks obtained in an ELISA, and not, for example, antibod-
ies attached to the well (which should be fully blocked), gold nanoparticles were
conjugated to the tertiary ELISA antibody. A PCEPy modified electrode was
incubated with primary anti-CTX Ab. A high concentration (10 µg mL-1) of
CTX was applied for 1 h at room temperature, to ensure thorough CTX bind-
ing to the capture antibody. A secondary anti-CTX antibody was applied for an
hour and washed, followed by the application of the AuNP-tagged tertiary an-
tibody, which was allowed to incubate for 1 h at room temperature. The chip
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FIGURE 3.9
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FIGURE 3.9: Initial studies for on-chip antibody tethering in-
volved the generation of a thiolated protein G self-assembled
monolayer on a bare Au substrate. This method resulted in non-
specific peak currents that were the same magnitude of specific
peaks. This persisted despite the exploration of numerous block-
ing methods. X axis represents potential; Y axis represents cur-
rent.
3.4. Dendrite surface modification 79
FIGURE 3.10
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FIGURE 3.10: (a) Generation of a PCEPy film can be confirmed
visually as a change from yellow to brown on bare gold (right)
or to a darker shade of brown on dendrites (left). White circles
encompass regions of PCEPy deposition. (b) After PCEPy film
electrogeneration, a monomer-free aqueous solution of NaClO4
was applied to three separate arrays on the same dendritic chip.
A peak around 400 mV is in agreement with published values for
the oxidation potential of cyanoethylpyrrole. X axis represents
potential; Y axis represents current.
3.4. Dendrite surface modification 81
FIGURE 3.11
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FIGURE 3.11: Electrochemical comparisons of 2 methods of
PCEPy electropolymerization on planar Au electrodes. (a) Gal-
vanostatic (constant current) deposition resulted in well-defined
PCEPy oxidation peaks, but (b) poorly formed 4-AP redox peaks.
(c) A potentiostatic (constant voltage) method gave broader
PCEPy oxidation peaks, but (d) much more well-defined 4-AP
redox peaks. All X axes represent potential; all Y axes represent
current.
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was removed from its housing, rinsed thoroughly with TBS and allowed to air
dry over night. The chip was then imaged via SEM for the presence of nanopar-
ticles ~40 nm in diameter (Fig. 3.12). Positive confirmation of AuNPs on the
dendrite surface indicated that all components of the full sandwich ELISA had
been successfully tethered to the chip. It is also indicative of the strength of the
electrostatic interaction between the primary capture antibody and the PCPEy
film, which by the final imaging had undergone 15 washing steps.
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FIGURE 3.12
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FIGURE 3.12: 40 nm AuNPs are conjugated to the tertiary
ELISA antibody. After the ELISA was performed (+ or - CTX),
chips were dried and imaged. Images are magnified at 40,000x.
The test condition, +CTX, is shown in duplicate, with red cir-
cles enclosing numerous (but not all) gold nanoparticles on the
dendrite surface, for better visualization.
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3.5 Functionalization for electrochemical sensing
3.5.1 Planar Electrode LOC
Proof-of-concept of a PCEPy facilitated LOC ELISA assay was first examined
on a planar gold-coated electrode. This is because a flat Au electrode represents
one of the simplest electrode architectures that can be used. More complex ar-
chitectures, such as dendrites, must justify additional fabrication steps with an
improvements in sensing capabilities. Otherwise, if more complex architectures
do not confer sensing advantages, there is not any reason to put effort into fabri-
cating them in lieu of a simple planar Au electrode.
A flat Au film electrode was prepared as described previously, with 10 nm Ti and
120 nm Au deposited on a Si wafer. The wafer was then diced into chips 15x15
mm in size. P200 pipette tips were cut to ~1 cm in height. The manufactured
end was glued to the chip using a two part epoxy and allowed to cure overnight,
creating individual wells (~19 mm2) on the same chip, isolated from each other
(Fig. 3.13).
The planar electrode was coated in a PCEPy film, functionalized with 1 mg
mL-1 of capture antibody, and then incubated with one of several concentrations
of CTX (0.5 ng mL-1 - 500 ng mL-1). The ELISA protocol was performed as
described previously (142). The chip was connected to a Gamry Reference 1000
potentiostat using a three electrode system for analysis. In this method, the 4-AP
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FIGURE 3.13
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FIGURE 3.13: A 10 nm/120 nm Ti/Au chip is divided into 3
sensing regions using pipette tips. Tips were adhered to the sur-
face with a 2 part epoxy by their manufactured end to ensure a
tight seal. CE and RE wires were inserted into the well, with the
gold surface acting as the WE.
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generated in the process was oxidized on the same planar gold surface where it
was generated, which is a step towards LOC sensing. A representative example
titration of different concentrations of CTX detected by the planar gold electrode
is shown (Fig. 3.14), where the magnitude of redox peak of 4-AP at -100 mV is
proportional to the amount of CTX in the sample. It should be noted that minor
deviations from -100 mV are seen for the peak currents, which may be attributed
to a slight voltage drift likely caused by the use of a pseudo-reference electrode.
Briefly, a pseudo-reference electrode is when an oxide layer is created on a bare
silver wire, making it Ag/AgCl. A RE should have a stable and well-known elec-
trode potential, but pseudo-REs experience unstable potentials, which can result
in voltage drift (160–162). It was necessary to use a pseudo-RE in these studies
due to the small size of the wells.
An ELISA of each CTX concentration was repeated in triplicate, and the av-
erage peak current was plotted against concentration (Fig. 3.15). The lowest
detectable concentration of CTX on the planar sensor was 100 ng mL-1, which
is not comparable to currently available diagnostic methods such as a standard
ELISA, which can detect at 1 ng mL-1.
3.5.2 Dendritic electrode LOC
Given the low sensitivity of the planar chip, the same protocol was then applied
to a dendritic gold sensor. We speculated that the increase in surface area af-
forded by the dendrites would provide a higher sensitivity due to an increase in
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FIGURE 3.14
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FIGURE 3.14: DPV signals from representative CTX dose titra-
tions on planar electrodes. DPVs were baselined at -200 mV to
elucidate the true peak current. CTX concentrations ranging from
0.5 ng mL-1 to 500 ng mL-1 were examined. Note that deviations
in peak redox potential from -100 mV were likely due to the use
of a pseudo-reference electrode, which may have caused some
minor voltage drift. X axis represents potential; Y axis represents
current.
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FIGURE 3.15
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FIGURE 3.15: Measurements of each concentration of CTX
were taken in triplicate. Peak current was plotted against concen-
tration of CTX to compare planar (circle) and dendritic (triangle)
sensor performance. Error bars represent the standard deviation
in peak current of 3 runs. X axis is CTX concentration; Y axis is
peak current.
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the number of antibodies tethered near to the chip surface. Removable wells of
~4 mm2 in area were used, creating 7 sensing regions on an individual chip in
order to minimize the effects of surface area variability that we have previously
observed (see Fig. 3.7). To ensure that the PCEPy coating did not drastically
negatively affect the sensing capacity of the dendrites, FCA measurements were
taken pre- and post-PCPEPy modification. As shown in Fig 3.16, while the
PCEPy coating does augment both the peak current and the shape of the oxida-
tion peak to a certain degree, the chip is still functional, and the redox peak is
still present and prominent. This indicates that the PCEPy coated chips can be
used for the on-chip ELISA with theoretically very little deterioration in signal
resulting from the polymer film.
Again, sensing regions were connected to a potentiostat, with a CE and RE
dipped into the well of interest for measurement. DPV signals from CTX dose
titrations (0.5 ng mL-1 – 500 ng mL-1) were measured, with a representative titra-
tion curve shown in Fig. 3.17. Measurements were performed in triplicate, both
on different chips and on different arrays on the same chip. Peak current data
was aggregated, as was shown in Fig. 3.15. Despite the known variability within
and between dendrite chips which results from the random nature of the crys-
tallization, peak currents for the ELISA were not highly variable. Additionally,
the dendritic ELISA-on-chip assay achieved a higher sensitivity than its planar
counterpart, detecting at 1 ng mL-1 of CTX over a smaller footprint (~4 mm2 vs.
~19 mm2), with a signal-to-noise ratio of 2.6 for this lowest concentration.
3.5. Functionalization for electrochemical sensing 95
FIGURE 3.16
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FIGURE 3.16: FCA measurements were taken before and after
modifying a dendritic electrode with a PCEPy film. The coating
did not affect the oxidation potential, and only minimally affected
the peak current magnitude. X axis represents potential; Y axis
represents current.
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FIGURE 3.17
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FIGURE 3.17: DPV signals from representative CTX dose titra-
tions on dendritic electrodes. DPVs were baselined at -200 mV to
elucidate the true peak current. (a) CTX concentrations ranging
from 0.5 ng mL-1 to 500 ng mL-1 were examined. Note that de-
viations in peak redox potential from -100 mV were likely due to
the use of a pseudo-reference electrode, which may have caused
some minor voltage drift. (b) Low concentrations are shown sep-
arately to better illustrate the 4-AP redox peak at 1 µ g/ml. X axis
represents potential; Y axis represents current.
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FIGURE 3.18
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FIGURE 3.18: Current density was used as a measure of the true
sensing improvement afforded by the dendritic chips. Peak cur-
rent was divided by the footprint area of the sensing region of
each chip, and plotted against the concentration of CTX. Den-
drite (circle) peak current density was compared against planar
(triangle). Error bars represent standard deviation of the peak
current of 3 tests. X axis is CTX concentration; Y axis is peak
current density.
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To normalize by footprint surface area, current density was used as a final means
of comparing the planar and dendritic sensors (Fig. 3.18). Current density is the
peak current at a specific concentration, divided by the footprint of the sensing
region. The superiority of the dendritic array is better highlighted in this compar-
ison, with dendrites on average demonstrating 18-25 times the current density of
planar gold. This is in good agreement with the increase in surface area demon-
strated in Fig. 3.7. Additionally, enhanced electric fields at sharp corners, of
which the dendrites have many, may also be responsible for some of the increase
in performance over the planar electrode.
Optical ELISAs remain one of the best methods of specifically and sensitively
identifying cholera cases. Thus, the electrochemical performance of the den-
drites was finally compared against the sensitivity of a standard optical ELISA
using the same series of antibodies (Fig. 3.19). The dendritic LOC ELISA and
a standard optical ELISA both demonstrate a limit of detection of 1 ng mL-1 of
cholera toxin. However, the dendritic array affords several advantages over a full
optical ELISA, which make it more amenable to POC use. The optical ELISA
is not highly portable, and requires laboratory infrastructure. So while highly
sensitive and specific, it is a test not available to most people affected by cholera
infections.
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FIGURE 3.19
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FIGURE 3.19: A log-linear (inset: log-log) comparison of den-
drite LOC performance (circle) and a standard optical ELISA
(triangle). Error bars represent the standard deviation of 3 tri-
als for each CTX concentration on each platform. X axis is CTX
concentration; Y axis is peak current density (dendrites) or ab-
sorbance at λ=600 nm (optical).
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3.6 Future directions
This novel biosensing platform is able to exceed the sensitivity of a simpler pla-
nar electrode, and is able to match the diagnostic sensitivity of a standard optical
ELISA. However, in its current iteration, the washing and reagent application
steps would not be ideal for POC use. Further work dictates the development
a microfluidic chip housing, as well as software to interpret electrochemical re-
sults for the end user.
Additionally, more extensive and controlled dendritic growth may be achieved
using a pillared gold substrate, rather than a planar one. Previous work has
shown that in this setup, dendrites will grow out from the sharp pillar tip (Fig.
3.20). Better control of dendrite growth may result in a more finely tuned chip,
with less variability from sample to sample.
It should also be noted that the method of tethering the antibodies to the surface
is via electrostatic interactions, which are susceptible to changes in pH. To over-
come issues caused by the pH of a sample, other conductive polymers should
be explored, especially those which can be modified in order to create covalent
bonds with biomolecules (163). This would include polymers with terminal re-
active groups like NH3 and COOH. For example, Hernandez, et. al. deposited
a pyrrole film onto glassy-carbon electrodes, which they then functionalized to
include nitro groups, which were later reduced to amine groups. A carbodi-
imide reaction linked their protein of interest to the amine group via carboxyl
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functionalities on surface amino acids (116). Others have used polypyrrole films
functionalized with avadin, which were able to tether biotinylated antibodies to
the surface (144). While both methods will create a more stable bond than the
electrostatic interactions utilized in the study undertaken in this thesis, they also
represent additional preparation steps. Increases in fabrication complexity must
be justified with increases in POC functionality, but it is an avenue worth ex-
ploring, especially for its potential to decrease primary antibody incubation time
(which is currently 48 hours for electrostatic interactions).
Moving forward, applications of this LOC setup are not limited to cholera de-
tection. Any biomarker for which there are effective antibodies commercially
available could be conceivably detected using this protocol. Further work may
include examining its efficacy in detecting other infectious disease biomarkers,
such as lipoarabinomannan, a putative biomarker for tuberculosis (164), or per-
haps for biomarkers of some cancers (157, 165).
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FIGURE 3.20
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FIGURE 3.20: Dendrites grown on a pillared gold substrate.
Scale bar represents 1 µm. Dendrites grow preferentially from
the tip of the sharp Au pillars. Image adapted from reference
(archibald_novel_nodate).
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3.7 Summary
Utilizing DENA, gold dendrites grown from a planar gold substrate were fab-
ricated. These dendritic gold sensors demonstrated ~18x the surface area of a
planar gold electrode of the same footprint. It was speculated that this increase
in surface area would result in a better sensing device, especially for the devel-
opment of a LOC, where all sensing reagents would be tethered in proximity to
the electrode surface.
To facilitate tethering of recognition elements to the sensor, the gold surface was
modified with a conductive polypyrrole film. This polymer was able to electro-
statically interact with OH groups on the primary capture antibody for a sand-
wich ELISA. A full ELISA was then completed on-chip, and the resulting redox
product, 4-AP, was oxidized to give a peak proportional to the amount of ana-
lyte in the sample. Dendrites demonstrated a sensitivity 2 orders of magnitude
greater than a planar counterpart. Thus, additional fabrication steps necessary to
create a dendritic sensor are justified.
To demonstrate the real-world utility of the dendrite sensor, its performance was
also compared against a standard optical ELISA. The dendrites were able to
match the sensitivity of this assay (1 ng mL-1). This is important as it shows that
decreasing the sensing area did not result in a loss of sensitivity.
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This dendritic sensor holds the potential to meet the A.S.S.U.R.E.D. diagnostic
demands of low cost, portability, and user-friendliness, while still maintaining
the sensitivity and specificity afforded by a standard ELISA. It is therefore a







Lab-on-a-chip electrochemical biosensing is limited largely by a lack of appro-
priate surface architectures. Signal transduction and overall sensor performance
is dictated by the electrode design, and so simplistic structures such as planar
gold may not be sufficient to maintain high sensitivity when the platform is
miniaturized (68, 166, 167). One strategy to overcome this limitation, as dis-
cussed in chapter 3, is to simply increase surface area, thereby increasing the
number of biological events happening in proximity to the electrode. An alterna-
tive and perhaps more promising strategy involves decreasing the gap between
electrodes to the nanoscale, termed nanogap electrodes (168, 169). Nanogap
electrodes display significantly different behavior compared to their macroscopic
counterparts, which can afford advantages in an ultrasensitive sensing capacity,
such as increased redox cycling (discussed in section 4.4.2) (127, 170, 171).
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A nanogap-based surface architecture, the nanocoax, was previously reported
which was able to both transmit visible light (172, 173), and detect volatile or-
ganic compounds (VOCs) (174). This nanocoaxial architecture has also been
used as an optrode for neurophysiology (175). Given the high sensitivity demon-
strated by the coaxes, it was theorized that they may also hold promise as a plat-
form for biosensing. Indeed, a first-generation nanocoax (Fig. 4.1), fabricated
using a facile nanoimprint lithography (NIL) process, was utilized for proof-
of-concept cholera detection using an off-chip strategy. This first generation
nanocoax was limited in true LOC utility because the nanoscale gap between
the working and counter electrodes did not allow for biofunctionalization of the
gold core. This was due to difficulties with reagent transport to the electrode
surface, likely caused by surface tension that was observed with increasingly
smaller nanogaps (archibald_novel_nodate). Additionally, once a reagent was
applied to the this sensing platform, it was extremely difficult, if not impossible,
to remove without the use of ethanol. For LOC, ethanol washing would disrupt
the biofunctionalized surface, meaning that this architecture was not well-suited
to further development as a POC diagnostic device. In order to overcome this
limitation, the gold core of the nanocoax was extended above the chrome shield.
This retains the nanocoaxial architecture with nanoscale proximity of the elec-
trodes, but also creates an unobstructed WE gold surface for biofunctionalization
which allows for simple reagent exchange. This new generation of nanocoax was
called the extended core coax (ECC) (Fig. 4.2). We believe that these features
will allow not only for true LOC detection, but will also be amenable to the
creation of user-friendly POC flow-through devices, since reagent entry into the
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nanogap is not necessary.
114 Chapter 4. Extended Core Nanocoax
FIGURE 4.1
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FIGURE 4.1: (a) A schematic representation of a first generation
nanocoax (non-ECC), which was fabricated via a nanoimprint
lithography process which created SU-8 pillars (red), followed
by metal deposition steps (Gold (Au): yellow; alumina (Al2O3):
blue; chrome (Cr): gray). The WE of the first generation was
nested within the CE, with a nanoscale gap separating them. (b)
A cross-section of nanocoaxes imaged by SEM, which shows all
metal layers. Image from reference (archibald_novel_nodate)
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FIGURE 4.2
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FIGURE 4.2: A schematic illustration of an ECC chip showing
coaxes in cross-section. Ti/Au (yellow) is deposited over Si pil-
lars (dark gray). A dielectric layer of alumina is deposited (blue),
followed by Cr (light gray). The extended core is created using
metal etching steps. (Image courtesy of Luke D’Imperio.)
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4.2 Aim of Study
Here, the ECC was first characterized and optimized, in order to demonstrate
that it was potentially a viable alternative to the first generation nanocoax (non-
ECC). Several iterations of the ECC architecture were fabricated, with FCA re-
dox as the benchmark assay for electrochemical performance. ECCs were then
biofunctionalized using a thiolated protein G. Protein G will specifically bind
the Fc region of an antibody and was used to tether a primary anti-CTX antibody
to the ECC WE. This antibody was used to capture cholera toxin, after which
ELISA was performed directly on-chip. The final antibody of the ELISA was
conjugated to ALP, which generates 4-AP when the substrate pAPP is added.
The ECC chip was then used to oxidize the 4-AP, where resulting redox peaks
were expected to be proportional to the concentration of CTX in the sample.
4.3 Fabrication and optimization
Silicon pillar chips 16x30 mm2 in size were thoroughly cleaned for metal de-
position. A 3:1:H2SO4:H2O2 piranha cleaning mixture was prepared. The WE
was formed by coating Si pillars with an adhesion layer of Ti (10 nm) followed
by 120 nm of Au, via sputtering deposition (Fig. 4.3a and b). Gold was chosen
as the WE metal due to its biocompatibility, amenability to biofunctionalization,
and relative inertness (176, 177). Given the small size of the electrode and the
nm scale thickness, using gold does not drastically increase the price of produc-
ing an ECC chip, though other cheaper metals, such as Cr, could also feasibly be
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used for the WE depending on experimental needs. A 200 nm dielectric layer of
Al2O3 was deposited via atomic layer deposition (ALD) to separate the WE and
CE (Fig. 4.3c). To serve as the CE, ~110 nm of Cr was deposited by sputtering
(Fig. 4.3d). To form the extended core, the Cr outer metal was first lowered
using a Cr specific etchant, exposing the Al2O3 layer (Fig 4.3e). The dielectric
was then etched (Fig. 4.3f), and electrode heights were confirmed with SEM
(Fig. 4.4). Further Cr and Al2O3 etching was done to yield varied heights of the
dielectric and shield according to experimental needs.
All arrays had a base area of 0.049 mm2 (Fig 4.5). Arrays were isolated from
each other for electrochemical measurements using a removable well system
held to the chip by pressure (as was used for dendrite chips and described pre-
viously). This ensured that no portion of the chip was damaged by epoxy, and
allowed for facile washing of the chip after use to examine re-usability.
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FIGURE 4.3
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FIGURE 4.3: A schematic illustration of the fabrication steps in-
volved in ECC production. One nanocoax is illustrated in cross-
section. (a) Base pillar silicon (Si) substrate. (b) Inner metal coat-
ing of gold (Au) to form WE (Ti not shown). (c) Dielectric alu-
mina (Al2O3) deposition. (d) Outer metal coating of chrome (Cr)
to form shield. (e) Outer metal etching to lower shield height. (f)
Dielectric etching to reveal gold core.
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FIGURE 4.4
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FIGURE 4.4: SEM of a finished ECC of the final iteration.
Coaxes have an annulus thickness of 200 nm, and a core com-
prised of Au extended ~200 nm above the Cr shield. SEM image
taken at a 30° tilt
124 Chapter 4. Extended Core Nanocoax
FIGURE 4.5
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FIGURE 4.5: An SEM of a single sensing array, showing Cr and
Au address lines to the CE and WE, respectively. Each com-
pleted ECC chip contains 7 of these arrays, which function inde-
pendently of each other.
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4.3.1 Nanoimprint lithography
In previous work, the non-extended core nanocoax was prepared on an SU-8
pillar array fabricated by NIL. Briefly, NIL involves making a stamp from a Si
master, that is used to shape SU-8 photoresist into pillars, which are then hard
baked and later overlaid with metals (178–180). We first attempted to use NIL
to generate base substrates for ECC fabrication, due to a low supply of avail-
able Si pillar arrays (Fig. 4.6). However, whereas the previous coaxial iteration
underwent a mechanical polishing step in order to expose the WE, ECC fabrica-
tion requires chemical etching to produce the extended core. The NIL process
resulted in base pillars that were slightly shorter than the Si master, and addition-
ally varied in the degree by which they were shorter. As detailed in the materials
and methods, formation of the extended core required first an extremely short
UV exposure (~1 s) of a photoresist layer which covers the chip surface after Cr
deposition (Fig. 4.7a and b). After exposure, only the very top of the Cr layer on
the ECCs was available, leaving the rest of the chip protected from the etchant
by the photoresist. When the pillar heights varied, the short UV exposure time
was not sufficient to consistently expose the entire chip. This left large swaths of
individual nanocoaxes covered in photoresist and unavailable for etching (Fig.
4.7c). As a result, chips produced with NIL were largely nonfunctional, and
those that did function were low-sensitivity. For this reason, further work was
performed on Si pillar chips only.
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FIGURE 4.6
128 Chapter 4. Extended Core Nanocoax
FIGURE 4.6: ECCs formed from a NIL process were not
amenable to electrochemical measurements. SEMs show that
cores are low aspect ratio, and their surfaces are imperfect and
cracked.
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FIGURE 4.7
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FIGURE 4.7: (a) The opening of the Cr tops after a UV flood
exposure. Features below the top are obscured by the layer of
photoresist that was not developed away. Only this topmost part
of the coax will be exposed to etchants. (b) The effects of NIL on
the final nanocoax. Large areas were not opened up for etching
due to height differences in the base substrate. This is visible as
fully white circles (left of image), rather than two concentric cir-
cles which would indicate a separate core and shield had formed.
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4.3.2 Optimization on Si substrates
To optimize the ECC fabrication on Si pillars, chips underwent several changes
in architecture, ranging from the shape of the extended core (dictated by Si pillar
shape), to the height of the CE and dielectric layers relative to the core. The
effects of all changes were measured by FCA redox and compared against the
non-ECC, in order to confirm that the changes contributed to either an increase
in sensing abilities, or at a minimum that they did not have a detrimental effect
on sensitivity. FCA is a commonly used redox species in electrochemical sens-
ing, which has been highly characterized (181).
Previous work characterized the ideal thickness for the annulus gap, which is
the dielectric layer between the WE and CE (127). In order to be a nanogap
electrode and allow for high sensitivity, the WE and CE must be in nanoscale
proximity. However, previous non-ECC iterations fabricated with small annu-
lus gaps (50-100 nm) experienced issues with liquid exchange and limitations
in washing steps, which was likely due to surface tension. Non-ECC chips with
sub-100 nm annulus gaps also experienced low manufacturing yield, likely be-
cause of shorting caused by the size of the gap. Because ethanol washes were
required to fully rinse the non-ECC nanogap (which limits biofunctionalization
by denaturing proteins and disrupting interactions (182)), and because of a need
for high manufacturing yield, an annulus gap of 200 nm was used for all ECC
chips.
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The first version of the ECC was built on very sharp Si pillars (Fig. 4.8a). These
chips showed a high level of sensitivity to FCA redox (Fig. 4.8b), with their cur-
rent density demonstrating about a 2-fold increase over the best-recorded per-
formance of the non-ECC. The Si pillar substrates on which these chips were
fabricated were not available for further manufacture, but due to the availability
of other types of Si pillars (Fig. 4.9), we instead explored ECC fabrication on
new substrates (Fig 4.10). Since small changes at the nanoscale can result in
large effects on function, we speculated that using Si pillars of different shapes
may result in chips with different behaviors. Ultimately, the decision to move
forward with a specific nanocoax shape was made based on a combination of
FCA redox data, electrochemical consistency within and between arrays, and
substrate availability. More specifically, a 1 µA current threshold was chosen
as the lower signal limit in response to FCA redox, in order to compete with
the electrochemical performance of the non-ECC. The NIL fabricated chips and
many of the cylindrical Si substrate arrays fell below this threshold, and addi-
tionally demonstrated inconsistency in measurements of FCA redox, and were
not used. A conical core shape was chosen for further optimization (Fig. 4.9a),
and was used to explore how the amount of shielded or unshielded WE may af-
fect sensitivity. Iterations were fabricated with a tall dielectric layer (Fig. 4.11),
tall CE shield (Fig. 4.12a), and finally a shortened CE shield and dielectric (Fig.
4.12b), relative to the core height.
These latter chips, which were comprised of nanocoaxes with a lowered shield
and dielectric layer, and a somewhat conical extended core with abundant gold
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FIGURE 4.8
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FIGURE 4.8: (a)The first ECC chips were built on sharp Si pil-
lars. (b) They demonstrated a high level of sensitivity to FCA re-
dox. Data represent 3 independent FCA redox trials on the same
ECC array. Image from reference (archibald_novel_nodate). X
axis is potential; Y axis is current.
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FIGURE 4.9
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FIGURE 4.9: Several types of Si base pillar substrates were avail-
able. FCA results, in addition to the availability of chips, dictated
the shape used for final testing. Slightly conical-shaped Si pil-
lars (a) were chosen for further work. Cylindrical pillars (b) did
not provide the electrochemical consistency necessary for further
use. SEM images taken at 30° tilt. Si substrates were imaged
with a layer of Au deposited for ease of visualization.
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surface area available for biofunctionalization, were chosen as the final ECC ar-
chitecture. Each chip was comprised of 7 individually addressed sensing arrays,
which each contained ~30,000 individual nanocoaxes, connected in parallel (Fig.
4.13).
Some issues with the ECC fabrication process which could affect chip function
should be noted. For example, at the perimeter of many sensing regions, there
was sometimes a strand of partially-connected material remaining (Fig. 4.14a).
This may arise from the photolithography process, specifically with the thin layer
of LOR resist used prior to SU-8 (183). We additionally experienced a problem
with crosslinking of the photoresist caused by SEM imaging (Fig. 4.14b), which
caused this photoresist to not develop away, and ultimately prevented the forma-
tion of ECCs in crosslinked regions.
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FIGURE 4.10
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FIGURE 4.10: Two examples of finished ECC nanocoaxes built
on a conical (left) or cylindrical (right) Si base, imaged by SEM.
Conical cores were ultimately chosen for further development.
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FIGURE 4.11
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FIGURE 4.11: An experimental iteration of the ECC, imaged by
SEM at a 30° tilt. These devices were fabricated with a lowered
Cr shield, but the dielectric layer was not significantly etched,
leaving it to cover much of the core. It was believed that in-
consistencies in electrochemical performance of chips was due
shorting issues caused by the shield and core touching on some
of the nanocoaxes in the array. Due to the sheer number of in-
dividual coaxes in an array (~30,000) and the number of arrays
(7), we could not rule this out with a simple visual assessment.
This iteration was created to prevent any chance of shield and
core coming into contact.
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FIGURE 4.12
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FIGURE 4.12: SEMs show nanocoaxes built on the same conical
Si substrate, with different shield heights. (a) Chip L075 with
high shield. (b) Chip L076 with low shield. FCA data run in trip-
licate on a representative array from each chip is shown below. X
axis is potential; Y axis is current.
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FIGURE 4.13
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FIGURE 4.13: The finalized ECC architecture represents an ar-
ray of vertically oriented nanocoaxes with lowered shield and di-
electric layers relative to the extended gold core. (a) Each chip is
comprised of 7 individually addressed sensing regions, (b) which
each contain ~30,000 individual nanocoaxes connected in par-
allel (image magnified 5,000x). (c) Bracket indicates that the
gold core extends ~200 nm above the shield (image magnified
100,000x).
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FIGURE 4.14
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FIGURE 4.14: SEM images of issues encountered during ECC
fabrication. (a) Partially-connected material from the lift-off pro-
cess remains on the edges of a sensing array. (b) A region of an
ECC array which did not form correctly because photoresist was
crosslinked and did not develop correctly.
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4.4 ECCs for electrochemical sensing
4.4.1 Quality control
Before being used in any biosensing capacity, ECCs underwent three quality
control steps: SEM imaging, resistance measurements, and FCA redox testing.
SEM imaging confirmed qualitatively that ECCs had been fabricated in the cor-
rect shape (lowered CE and dielectric). Resistance between the WE and CE was
measured to ensure that arrays were not shorted. Resistances in the GΩ range
were considered acceptable for use. It is worth noting that chips with resistances
at or below the MΩ range were fabricated which were still functional, which is
unusual as this would normally suggest these chips were shorted. Indeed, these
low resistance chips actually demonstrated a significant improvement in FCA
redox signal over higher resistance chips (Fig. 4.15). This difference may be
due to the formation of an oxide layer on the high resistance chips, meaning
that the Si substrate may actually be SiO2. The DC resistivity of SiO2 is on the
order of ~1017 Ωcm, while Si is ~105 Ωcm (184, 185). It is likely that in the
low resistance chips the Si substrate may be contributing to conducting the sig-
nal. While these chips appeared to be much more sensitive to FCA redox, they
were prone to current overloads and gave highly inconsistent oxidation peaks.
For this reason, it was decided to continue to disregard low resistance chips for
further work. As a final measure of quality control, FCA oxidation was per-
formed to evaluate both chip current density and consistency. Generally, only
arrays demonstrating ≥ 1 µA of FCA oxidation current were used for further
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experiments. A 1 µA threshold for FCA redox current was chosen based on past
electrochemical performance of the non-ECC, with which the ECC must com-
pete. While the non-ECC initially reported extremely high sensitivity to FCA
(~80-150 µA mm2), all chips experienced a degradation in signal in subsequent
runs, eventually stabilizing at ~25-30 µA. Thus, given the reduced size of the
ECC sensing region vs. the non-ECC, a peak of only 1 µA on the ECC gives a
current density of ~20 µA/mm2, which sufficient to surpass the stabilized current
density of the non-ECC (~14µA/mm2). It is also worth noting that the ECC did
not experience the signal degradation from one test to the next, which is in itself
a significant improvement over the non-ECC.
4.4.2 Electrochemical performance
As stated previously, a nanocoaxial architecture has achieved ultrasensitive de-
tection of VOCs. This was done by measuring a change in capacitance in re-
sponse to the presence of a gas. This method was not explored for biosensor
development, however, due to the generation of an electric double layer which
hindered capacitive sensing on the non-ECC. Briefly, a double layer is when
ions from a solution are adsorbed onto a substrate (in this case, the electrodes),
and then oppositely charged ions from the solution are in turn attracted to the
adsorbed ions (186). Because of this DPV was chosen as the method of detec-
tion for the non-ECC (142). DPV is able to suppress capacitive charge by using
short pulses of potential (Fig. 4.16), allowing the electrode to discharge between
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pulses (187). This method was similarly employed for the ECC.
A removable well system was attached to both ECCs and planar controls, and
was filled with 60 µl of 1 mM FCA in PBS, pH 7.4. DPV was performed in the
potential range of 0-500 mV, with FCA oxidation peak occurring ~300mV. ECCs
were compared against non-ECCs and planar electrodes, and Fig. 4.17 illustrates
the difference in current density (peak current/area) between each platform. Cur-
rent density is used as a measure of comparison because even though the planar
and ECC chips were measured using identical wells, the active electrode areas
are not the same. The sensing region of the ECC (0.049 mm2) is much smaller
than the footprint of the well that encompasses it (~4 mm2). The ECC sensing
region is also smaller than that of the non-ECC (1.8 mm2). The increase in cur-
rent density the both nanocoaxial architecures exhibit over planar may be due
to the phenomenon of redox cycling. Redox cycling occurs between nanogap
electrodes, where a species in oxidized at the WE, then reduced at the CE, where
it can then rapidly diffuse back to the WE to be oxidized again (188, 189). Im-
provement in signal can be obtained by decreasing the size of the annulus gap,
which may allow for faster redox cycling (127).
The increase in current density that the ECC exhibits over the non-ECC may
be explained by the ease of liquid exchange. As stated previously, due to sur-
face tension it was difficult for solution to diffuse to the WE which was situated
within the annulus gap. By contrast, ECC WE extends into the solution, and so it
may be easier for FCA molecules to move from the bulk solution to the electrode
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surface to be oxidized.
From this comparison, it is clear that both nanocoaxial architectures are better-
performing than a simple planar electrode. While the drawbacks of the non-
ECC have been discussed above, the ECC is not without its own issues. While
ECCs did not experience the significant drop in peak current from run to run that
plagued the non-ECC, and indeed were extremely consistent within the same
sensing region (Fig. 4.18a), arrays did display significant differences in peak
current between sensing regions (Fig. 4.18b). Similarly, ECC chips fabricated
within the same batch also demonstrated highly variable peak currents in FCA
tests (Fig. 4.19). However, as long as peak currents exceeded the current density
threshold of 1 µA, chips were still used. This is because we believed that the
highest current achievable in a LOC ELISA would always be much smaller than
1 µA, and thus the variability may not significantly impact these results.
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FIGURE 4.15
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FIGURE 4.15: Representative FCA oxidation peaks on a chip
exhibiting kΩ (low) resistance vs. one exhibiting GΩ (high) re-
sistance. Data represent one trial on one array from each chip. X
axis represents potential; Y axis represents current.
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FIGURE 4.16
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FIGURE 4.16: Potential waveform used in DPV. Potential is
pulsed in increasing increments for short bursts of time. This
minimizes the effects of capacitive charging. X axis is time; Y
axis is voltage.
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FIGURE 4.17
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FIGURE 4.17: A comparison of average current density achieved
in sensing FCA redox between a representative ECC array (three
independent runs one one array), a non-ECC array (reported val-
ues one array, after stabilization) (190), and a planar gold elec-
trode (three independent runs on one array). For the non-ECC,
data is reported which excludes the highest FCA current mea-
sured on the array, which was achieved on a virgin chip. All
trials subsequent to the first run gave a significantly diminished
peak current, which may be more indicative of the true sensing
capacity of the platform. X axis is sensing platform; Y axis is
peak current density.
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FIGURE 4.18
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FIGURE 4.18: (a) ECC chips generally demonstrated an ex-
tremely high degree of consistency in FCA readings within an
array. Data represents 3 trials on the same array on ECC chip
L105, run consecutively with no washing step in between. (b)
Peak current between different arrays on the same chip varied sig-
nificantly. Data represent one trial from each array on the same
chip. Array 2 is not represented due to shorting issues. X axis is
potential; Y axis is current.
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FIGURE 4.19
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FIGURE 4.19: The variability in FCA peak current of a batch of
chips fabricated at the same time. The peak current of all trials
on all functional arrays was averaged for each chip. Error bars
represent the standard deviation of all peak currents measured on
each chip individually. X axis is chip identification number; Y
axis is peak current.
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4.5 Off-chip biosensing
After fabrication optimization and confirmation of electrochemical function, ECCs
were used to measure their biosensing performance compared to the non-ECC.
Non-ECCs had previously been used to detect CTX in an off-chip setup; that is,
all ELISA steps were performed in a standard 96 well microtiter plate, with only
the final redox product applied to the chip surface for detection. This made the
non-ECC more of a novel analysis platform than a true LOC.
A titration of ALP was performed to provide a baseline of the biosensing po-
tential of the ECC. Serial dilutions of ALP were made, incubated with 1 mM
of the substrate pAPP, and then pipetted on to the ECC chip for electrochem-
cial analysis (Fig. 4.20). This was done to demonstrate that the ECC is capable
of detecting the redox product of an electrochemical ELISA (4-AP), before we
moved on to test the full sandwich ELISA. Titration data was taken on a single
array to circumvent any issues with the variation between sensing regions. In
this assay, an ECC chip was capable of detecting 10 ng mL-1 of ALP, confirming
the ECC as a viable candidate for further biosensor development.
As a baseline comparison of the non-ECC and the ECC, an off-chip electrochem-
ical ELISA, developed previously, was performed (142). CTX was chosen as the
biomarker of interest due to its clinical relevance, stability and safety. The off-
chip ELISA was performed identically on the ECC as it was on the non-ECC,
which in turn was identical to a standard optical ELISA with the exception of
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the readout. For the electrochemical ELISA, pAPP was added as the enzymatic
substrate as opposed to Bluephos for the optical readout. The ECC off-chip read-
out showed a comparable level of CTX sensitivity as the non-ECC (Fig. 4.21).
Both were able to detect as low as ~1 ng mL-1 of CTX. When current density was
taken into account, however, the ECC outperformed the non-ECC, as the sensing
area of the ECC was significantly smaller than that of the non-ECC (Table 4.1).
Thus, if the ECC were scaled up from 0.049 mm2 to 1.8 mm2 to match the size
of the sensing area of the non-ECC, the ECC would measure a higher current in
response to 4-AP oxidation.
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FIGURE 4.20
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FIGURE 4.20: DPV signals on an ECC array for an ALP titra-
tion. Different concentrations of ALP were incubated with pAPP.
The redox product 4-AP was oxidized on one array of an ECC
chip. DPV signals were subtracted to a baseline at -200 V. A
shift in the oxidation potential of 4-AP may be due to the use of a
pseudo-reference electrode. X axis is potential, Y axis is current.
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FIGURE 4.21
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FIGURE 4.21: (a) An electrochemical ELISA performed off-chip
for CTX titrations, and analyzed on the ECC. All measurements
were made on the same ECC array to minimize variability. Data
were subtracted to a baseline at -200 mV to better elucidate peak
currents. Sharp peak seen in the 1 µg/ml data is an artifact, and
not relevant to the redox reaction taking place. X axis is potential;
Y axis is current. (b) The peak current density at each CTX con-
centration, as measured on an ECC chip and a non-ECC chip are
compared. X axis is CTX concentration; Y axis is peak current
density.
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4.6 Functionalization of ECCs
Once the ECC proved to have comparative off-chip functionality to the non-
ECC, the feasibility of true LOC detection was explored. The ECC was devel-
oped primarily to provide structural differences that would overcome sensing
limitations of the non-ECC. Namely, the extension of the WE outside of the
CE provides a substrate for biosensor development that may not be hindered by
surface tension, which will allow for thorough washing and subsequent biofunc-
tionalization.
The PCEPy protocol described in chapter 3 was first implemented for antibody
tethering on the ECC. However, PCEPy oxidation peaks at -400 mV were not
detected after polymerization (Fig. 4.22), indicating that PCEPy was likely not
electropolymerized, and that subsequent antibody binding was not possible. This
is likely because PCEPy will deposit on the WE. In the case of the dendrites, the
WE is comprised of the entire chip surface. For ECCs, the WE is only the gold
core of each nanocoax. There does not seem to be enough WE available to elec-
tropolymerize that would give rise to a redox peak. As an alternative, a protein
G protocol was evaluated.
Protein G is a bacterially derived protein with specific affinity for the Fc region
of IgGs (191, 192). This protein was modified with a thiol group, in order to
facilitate binding with a gold surface (193). To provide a visual proof-of-concept
of protein G-facilitated antibody tethering, a 1 mg mL-1 solution of thiolated
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protein G was applied to an ECC chip for 2 h at room temperature, with rocking.
It was then thoroughly rinsed with TBS, and incubated for 12 h with ELISA
tertiary antibody. This tertiary antibody was conjugated with a 40 nm AuNP to
allow for SEM visualization of tethering. The chip was then removed from its
well housing, rinsed thoroughly in TBS, and dried with N2 air. SEM images of
a control array (no protein G) and test array (protein G) on the same ECC chip
are shown in Fig. 4.23. It should be noted that because it was expected that this
process would be damaging to the ECC chip and possibly preclude further use,
an older chip with a slightly different architecture was used. Since this assay
was purely of a visual nature, results were expected to be representative of the
behavior of the ECCs used for electrochemical studies. AuNPs about 40 nm in
size are visible surrounding the extended cores of the test array, but not around
the cores on the control array. This provided visual proof that the extended gold
core is indeed amenable to biofunctionalization, and could feasibly be used for
LOC detection of biomarkers using a sandwich ELISA setup.
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FIGURE 4.22
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FIGURE 4.22: Functionalization facilitated by a PCEPy film was
first attempted on the ECCs. Results of PCEPy oxidation are
shown for multiple arrays on the same ECC chip, in a solution of
NaClO4 containing no monomer. PCEPy oxidation should occur
around 400 mV. Measurable PCEPy oxidation peaks were not
observed after electropolymerization on any array. Data for array
2 is not shown because of shorting issues. X axis is potential;Y
axis is current.
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FIGURE 4.23
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FIGURE 4.23: SEMs of 2 separate arrays on the same ECC chip,
one which was incubated with protein G (+ prot. G) prior to
AuNP conjugated antibody application, and one which was not
(- prot. G). For each test condition, two images are shown at
different magnifications, to provide context. AuNPs of ~40 nm
in diameter are visible around the extended cores of the test array,
but not the control array. Note that an older iteration of ECC was
utilized in this study, but is expected to be representative of the
behavior of all ECC chips.
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4.7 ECCs as LOC biosensors
To biofunctionalize the ECC toward LOC detection, 1 mg mL-1 of thiolated pro-
tein G was incubated on-chip for 2 h, and rinsed thoroughly with TBS. A primary
ELISA anti-CTX antibody diluted to 1 mg mL-1 in HEPES was incubated on the
chip for 48 h to allow for thorough binding of the antibody Fc region to the pro-
tein G layer. The chip was blocked with 5% BSA and 5% glycerol in TBST
for 1 h. The remaining steps of the ELISA procedure, detailed in section 2.7,
were performed on-chip, with washes between each. While this work is prelimi-
nary, Fig. 4.24 demonstrates preliminary on-chip detection of CTX by a protein
G functionalized ECC. The dendritic LOC was capable of a maximum current
density of ~0.4 µA/mm2; by contrast, these preliminary ECC data demonstrate
that the ECC achieved a current density of ~3µA/mm2, a 7-fold increase. While
more replicates and a full titration are necessary to confirm these findings, from
the standpoint of a proof-of-concept, these data are promising.
A final important feature of the ECC as compared to the non-ECC is their amenabil-
ity to repeated use. The non-ECC chips, as stated previously, demonstrated a sig-
nal degradation over the course of several uses. By contrast, ECC chips main-
tained signal integrity even after repeated use (Fig. 4.25), suggesting that the
ECCs, despite their small size, are relatively stable structures. This is important
for POC sensing potential, as portable diagnostic tools are typically not stored in
ideal conditions. The ECCs chips appear to be able to withstand a large amount
of use while maintaining their sensing integrity. For all these reasons, the ECC
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represents a significant improvement over the non-ECC architecture, and is a
promising architecture for further development toward POC cholera detection.
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FIGURE 4.24
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FIGURE 4.24: Preliminary data suggests a potential for ECCs
to be used for LOC deteciton of CTX, using protein G to tether
antibodies to the sensor surface. Each trial was performed on a
separate array on the same ECC chip. Data represents one trial
for each condition. Data were subtracted to a baseline at -200
mV to better elucidate peak current. X axis is potential; Y axis is
current.
178 Chapter 4. Extended Core Nanocoax
FIGURE 4.25
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FIGURE 4.25: Results of multiple FCA oxidation tests run on
one array of ECC chip L057. No washing steps were utilized in
between trials. X axis is potential; Y axis is current.
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4.8 Future directions
We have demonstrated that the ECC architecture is a viable and promising alter-
native to a first generation, non-ECC nanocoaxial architecture. However, there
are still several hurdles preventing the realization of the ECC as a true LOC for
POC diagnosis. The labor-intensive nature of chip fabrication, as well as chip
variability and failure rate, has precluded us from completing on-chip detection
of a full range of CTX concentrations. Once this is done, the performance of the
ECC should be compared to that of a standard optical ELISA, to ensure that it
has conferred some sensing advantage. However, given the advantages afforded
by the ECC, namely its potential for multiplexed biomarker detection on a highly
portable platform, a small decrease in sensitivity may still be acceptable in light
of other features. Future directions may also include examining more Si pillar
shapes. For example, given the tendency for electric fields to concentrate around
sharp edges, and given the performance of the very first ECC iteration which
was built upon sharp pillars, it may be worth examining the use of a sharp, high
aspect ratio Si pillar array fabricated in-house using the Bosch process (or reac-
tive ion etching) (Fig. 4.27).
Aside from this, in its current iteration, the detection platform is not yet portable
or user friendly. It is necessary for all reagents to be pipetted on to the chip, and
for the user to manually wash after each step. Such a setup is not acceptable
for A.S.S.U.R.E.D. diagnostics, which dictate as little end-user participation as
possible. To overcome this, the next step is to develop a microfluidic channel
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FIGURE 4.26
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FIGURE 4.26: Very sharp, high aspect ratio Si pillars fabricated
by reactive ion etching represent a potential substrate for further
ECC development. These pillars more closely resemble the Si
substrate used to manufacture the first ECC iteration, whose sens-
ing capabilities have not yet been recapitulated. (Images courtesy
of Jeffrey Naughton)
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system that integrates with the chip. Such a system would have wells for each
reagent and wash buffer. Ideally, the end user would only have to add sample to
begin the diagnostic test. Also problematic is the use of a desktop computer and
a full-sized potentiostat for the electrochemical analysis. In order to make the
analysis portable, a miniaturized platform built around a smart phone is neces-
sary.
Integration of the ECC with a portable, smart phone-based user interface, and a
low-participation microfluidic system has the potential to make the ECC a pow-
erful tool for POC cholera diagnostics. Additionally, the affinity of protein G for
any IgG means that the assay can be used to detect any biomarkers for which
antibodies are available. This opens up the possibility for detection of numerous
other diseases of poverty.
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4.9 Summary
Nanocoaxial-based sensing devices were fabricated with surface features meant
to overcome previous limitations. The WE core of the nanocoax was extended
outside of the CE shield, in order to make the surface available for biofunction-
alization. Additionally, the nanoscale gap between the WE and CE was main-
tained, which was previously shown to confer sensing advantages to nanocoaxes
(127). These new ECC chips were compared to the standard set by the non-
ECC in terms of electrical performance and off-chip sensing abilities. The ECC
demonstrated the ability to detect 4-AP, the end product of an electrochemical
ELISA. Further, it was able to match the sensitivity towards CTX in an off-chip
setup set by the non-ECC, of 1 ng mL-1. This detection limit is comparable to a
standard optical ELISA.
The ECC had numerous advantages over the non-ECC, however, which allowed
for improved sensing features. The ECC did not experience any signal degra-
dation in between uses, which the non-ECC experienced to a significant degree
(~150 µA to ~25 µA). Additionally, the ECC demonstrated amenability toward
biofunctionalization using a thiolated protein G to tether a primary ELISA an-
tibody. This biofunctionalization strategy was employed to obtain preliminary
data suggesting that the ECC is a more sensitive LOC than a simpler dendritic
gold or planar gold architecture, based on current density.
With further development, including the manufacture of more sophisticated chip
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housing which incorporates microfluidics and a portable analysis system, the
ECC is an attractive candidate for LOC detection of infectious disease biomark-




Discussion and concluding remarks
POC use of a standard optical ELISA is limited by the necessity for non-portable,
complex instrumentation, which requires a centralized diagnostic facility and
trained personnel to perform. Previous work established an electrochemical
ELISA assay which was able to match an optical ELISA with regards to CTX
detection limit in an off-chip format. That is, the optical and the electrochemi-
cal ELISA were both performed in a microtiter plate, with the electrochemical
product 4-AP later added to a nanocoaxial array for redox. Architectural fea-
tures of this nanocoax limited its use to only off-chip applications. In this work,
two other architectures, the gold dendrite array, and the extended core nanocoax,
were explored for their utility as LOC sensors for the detection of CTX with an
electrochemical ELISA. By performing the assay on a miniaturized on-chip plat-
form, these nanoarchitectures hold the potential to be highly portable, low-cost
and user-friendly alternatives to an optical ELISA, while maintaining a compa-
rable diagnostic sensitivity. Due to these advantages, both gold dendrites and the
ECC are promising candidates for further development into fully integrated LOC
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biosensors. A summary of cholera detection by the various methods employed
in this thesis is shown in table 5.1.
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TABLE 5.1: CTX detection methods
Detection method Sensing Area (mm2) Detection Limit (ng/mL)
Optical 320 1
Planar LOC 19 100
Dendrite LOC 4 1
Non-ECC off chip 1.8 2
ECC off-chip 0.049 1
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5.1 Dendrites
In this study, we sought to improve upon the sensitivity of a simple planar gold
architecture by increasing its surface area. This was accomplished through the
growth of nanostructured gold crystals on a planar gold electrode using a facile,
one-step method called DENA. Our results represent the first use of a gold den-
drite architecture functionalized with conductive polymer (PCEPy) for the elec-
trochemical immunodetection of CTX. This novel platform eliminates the neces-
sity for expensive and sophisticated optical instrumentation frequently required
for state-of-the-art diagnostics. Moreover, it represents a significant reduction in
reagent consumption, especially when compared to a standard optical ELISA.
While a standard ELISA in a microtiter plate requires 100 µl of each antibody,
here we have been able to reduce that to ~30 µl, with the potential to reduce
further to the nL range with a more sophisticated chip housing incorporating
microfluidic channels. As a result, the cost of this protocol per assay is lower
compared to an optical ELISA. Additionally, the small size of the electrode and
its simple electrochemical readout allows the device to maintain a high degree
of portability. Its low power needs (in the µW range) means that analysis can be
performed using a smart phone. This opens up the possibility for the creation of
a user-friendly interface, which lessens the impact of human error in misdiag-
noses.
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While these chips did not have nanoscale proximity of the WE and CE, increas-
ing electrode surface area is a frequently employed strategy for maintaining sen-
sitivity on miniaturized platforms (194, 195). This has included the use of high-
roughness electrodes (such as highly porous Pt films) (196), nanoparticles (197),
nanotubes (197, 198), and nanorods (199), as just a few examples of sensor mod-
ifications that result in and increase in effective sensing area without increasing
geometric area. In fact, similar to the strategy explored in this thesis, Wang, et.
al. used a polypyrrole coating on their high-surface area Pt electrode to create a
sensitive glucose detector, by immobilizing GOx within the polymer film (196).
An increase in sensitivity was directly attributable to the increased surface area,
which facilitated the capture of a greater number of sensing components on the
electrode than would be possible on a planar surface.
DENA in particular has proven to be a popular means of easily increasing sensor
surface area. Most DENA studies have focused on explorations of fabrication
parameters (148, 153–155, 200), but several proof-of-concept biosensors based
on this platform have been reported. Soleymani, et. al. have used dendrites to
rapidly detect bacterial mRNA (201), while Fang, et. al. were able to detect
cancer biomarkers on a multiplexed nanostructured electrode (202). Infectious
disease biomarkers have also been detected using dendritic architectures, includ-
ing HIV and rubella (158, 203).
We have focused our work on the detection of CTX using a dendritic array. A
popular method for LOC cholera detection is to exploit the affinity of CTX for
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GM1 gangliosides (9, 90, 204–206). However, antibodies may be more desir-
able capture elements for POC applications compared to GM1, both because the
sialic acid (Neu5Ac) glycosidic linkage is labile (207), and thus less amenable
to POC deployment, and because the use of GM1 severely limits the scope of
use of the sensor to only those toxins which interact with it.
While numerous commercial rapid diagnostic assays have been developed as
alternative detection methods for cholera, only a few have been found to hold
promise for POC applications (16). These diagnostics tend to fall into two cat-
egories: agglutination or colorimetric immunoassays. The major drawback of
such tests is the possibility for inconclusive results due to their readout mecha-
nism. For example, in their assessment of one such tool, Ley, et. al. found that a
major source of error came from users misinterpreting the lines on colorimetric
assays (21). For this reason, we chose to focus on an electrochemical detection
method for its ability to directly transduce biological events into a simple elec-
trical readout.
PCEPy was chosen for antibody tethering because use of intrinsically conductive
polypyrroles is popular and widespread in biosensing applications (208, 209).
Other strategies for tethering antibodies to electrodes for biosensing applica-
tions have been reported, including using self-assembled monolayers (210, 211),
hydrogels (212), coated beads (9, 213) and avadin-strepdavadin binding (214).
However, the ease and gentle conditions of polypyrrole polymerization, as well
as the electroconductive stability of the film, make polypyrrole a more attractive
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tool for fabrication of LOC devices with POC utility (215). As a result, pyr-
role and its derivatives have been used in biosensors ranging from neural probes
(216), to glucose sensing devices (217) and DNA biosensors (218). When com-
bined with antibodies as a biorecognition element, N-substituted polypyrroles
with terminal cyano groups (such as PCEPy) have been utilized to construct im-
munosensors via electrostatic (102) and electrochemically-directed (103) tether-
ing of antibodies to the surface of gold electrodes. In both cases, interactions
between antibody OH groups and the terminal CN group of the polymer film
were used to tether the antibody to the electrode surface. This afforded a higher
level of control over the antibody orientation than would be possible on a bare
gold substrate, which is important in order to preserve the availability of the
antigen-sensing region for analyte recognition.
5.2 Extended core nanocoax
We report progress on a novel nanoarchitecture, the extended core nanocoax
(ECC) that has applicability for the detection of biomarkers as a LOC device.
This work sought to improve upon a non-ECC nanocoax for the detection of
CTX. The architecture represents a vertically oriented nanocoax comprised of a
gold inner metal core that extends ~200 nm above a chrome outer metal shield,
separated by a dielectric annulus. Each ECC chip contains 7 discrete sensing
arrays, 0.049 mm2 in size, containing ~30,000 nanoscale coaxes connected in
194 Chapter 5. Discussion and concluding remarks
parallel. The non-ECC demonstrated a detection limit of 2 ng mL-1 of CTX us-
ing an off-chip setup. This sensitivity compares favorably to the standard optical
ELISA used in clinical settings. The ECC matches this limit, but additionally
offers the benefit of biofunctionalization on the extended gold core.
The ECC is a nanogap biosensor device. Nanogap devices provide attractive
prospects for the development of ultrasensitive diagnostic tools, and much atten-
tion has been given to those based on field-effect (FET), impedance, or capac-
itive sensing, where entrapped biomolecules will cause a change the electrical
behavior between the electrodes (219, 220) . In this study, we have used an am-
perometric method in order to exploit a unique electrical behavior of nanogap
electrodes, wherein the nanoscale proximity of the WE and CE in these devices
potentially allows for increases in sensitivity through the phenomenon of redox
cycling. Redox cycling has proven to be an efficient amplification strategy when
dealing with redox active molecules, especially when these molecules are in a
low concentration (221). For example, redox cycling has been an important strat-
egy for detecting the oxidation of neurotransmitter molecules contained within
vesicles (188). Exploiting this phenomenon relies on the development of ar-
chitectures that miniaturize and closely integrate electrodes. We therefore have
developed the ECC as a nanogap sensor which enhances redox activity through
the nanoscale proximity of a working and counter electrode.
Alkaline phosphatase (ALP) is an extremely common reporter for amplified
biomolecule detection (222–225). As such, ALP has also found use in nanogap
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electrode systems because of its high turnover frequency and high reaction se-
lectivity (226). For example, Hall, et. al. fabricated a nanogap-based transducer
array utilizing an ALP reporter as a novel DNA sequencing platform (227). ALP
was similarly employed in our studies.
ECC fabrication aimed to address architectural demands dictated by the electro-
chemical performance of the non-ECC. Briefly, electrochemical function of the
non-ECC was reliant on fluids entering the annulus gap between the WE and
the CE. The size of this gap presented several issues, including difficulties in
fluid exchange and in diffusion of reagents. For LOC utility, it is necessary to
be able to biofunctionalize the chip surface, which requires numerous reagent
and wash buffer applications. As a result, the non-ECC did not possess LOC po-
tential, and was relegated to off-chip detection. By contrast, the ECC maintains
the nanocoaxial architecture, and thus also maintains the nanoscale proximity of
the WE and CE, but the WE has been extended ~200 nm above the CE, and the
depth of the annulus gap has been lessened. It was anticipated that these features
would decrease the surface tension which we believe prevented fluid exchange,
while additionally providing significantly more gold surface area for potential
biofunctionalization (228, 229).
Indeed, the ECC demonstrated several performance advantages over the non-
ECC. First, we showed that the ECC demonstrated a higher degree of consis-
tency in response to FCA redox than its predecessor. Its electrochemical perfor-
mance was also superior to the non-ECC when comparing current density; that
196 Chapter 5. Discussion and concluding remarks
is, the ECC can detect more current over a smaller area than the non-ECC. The
ECC has proven to be more robust than the non-ECC, by demonstrating a high
degree of re-usability and maintaining electrochemical integrity over repeated
use. In a comparison of off-chip ELISA results, the ECC matches the detection
limit of the non-ECC, which is comparable to a standard optical ELISA. Finally,
we were able to obtain visual and preliminary electrochemical data suggesting
that the extended gold core is amenable to functionalization with antibodies us-
ing a thiolated protein G as an intermediate tethering protein. Protein G was
chosen due to its ability to correctly orient antibodies with their Fab away from
the sensor surface, because of an affinity to bind the Fc. Taken together, this
data makes a strong argument for the use of ECC chips as LOC detectors of
infectious disease biomarkers. Further development, including improvements
towards portability and automation, could produce a device capable of meeting
POC demands.
5.3 A.S.S.U.R.E.D. diagnostics
For both platforms to find utility as fully realized POC devices, it is necessary to
address the A.S.S.U.R.E.D. concerns set forth by the WHO (230). We believe
that the surface architectures and assays detailed herein are capable of meeting
most of the needs dictated by the unique environment of low-resource locations,
which is created by a limitations in funding, infrastructure, and/or trained per-
sonnel. In regards to cholera specifically, all of these factors play a large part
5.3. A.S.S.U.R.E.D. diagnostics 197
in its endemic presence in over 50 countries, in addition to its frequent reemer-
gence as an epidemic. Limited sanitation infrastructure leads to contaminated
drinking water, which is consumed by people who are frequently malnourished,
allowing cholera to survive the stomach to colonize the intestines. Widespread
infection and numerous deaths weakens the workforce, contributing to poverty,
which hinders infrastructure improvements. For endemic countries, being locked
in this cycle has allowed one outbreak of cholera to persist for close to 60 years
(231).
The WHO criteria for affordability puts a constraint of $500.00 per machine
used, and $10.00 per test. Despite the use of gold in both the dendritic array
and the ECC, the largest cost associated with their manufacture is manpower. It
is conceivable that scaling up the fabrication process would allow for this $10
target to be met. We propose that analysis be performed with the use of a smart-
phone, which are increasingly common even in resource-limited settings, which
would fall well beneath the threshold of $500.00.
As detailed herein, the dendritic array is capable of matching a popular diag-
nostic standard, the optical ELISA, for sensitivity toward CTX (sensing at 1 ng
mL-1). Specificity is measured in regards to correctly identifying individuals who
are disease-free, which would necessitate clinical samples to accurately assess
(232). For the purposes of our study, our assays showed high specificity towards
samples of CTX diluted in a BSA containing buffer.
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In regards to user-friendliness, the WHO suggests that it take no more than 1 to
2 days to train personnel to use a device. While that is not possible in the current
iteration of our assays, we propose to develop a user-friendly interface based on
a smartphone which could guide users through a testing procedure. Additionally,
the electrical readout afforded by the electrochemical assay we have developed
would give simple results, uncomplicated by optical interpretations. We believe
this will reduce diagnostic error which result from human involvement.
Demands for rapidity and robustness are that tests take no more than 30 minutes,
utilize a minimum amount of consumables (i.e. pipette tips), and have a shelf
life of a year. Given the necessity for thorough antibody binding, an ELISA is
not capable of meeting this timing demand. It is conceivable that the sandwich
ELISA used in our assay could be reduced to 2 antibodies, which would cut an
hour from analysis time. In its current iteration, many consumables in the form
of pipette tips are necessary. Moving forward, a microfluidics system would
eliminate most or all of this waste, making the only consumable the chip itself.
Shelf life has not yet been examined for either functionalized dendrites or func-
tionalized ECCs. However, both chips are physically very robust, and able to
maintain function despite abundant handling and prolonged storage (longer than
a year).
Equipment-free means that a device should be compact, battery-powered (al-
lowing for on-site analysis and easy handling), and disposable. Chips are not
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fabricated with any toxic components, and so would not present an issue for dis-
posal. As stated previously, the electrochemical ELISA represents an assay with
low power needs. It is entirely possible for all necessary power to be provided
through a smartphone USB port. The potentiostat can be likewise be replaced
with either a hand-held potentiostat (233), or even more portable, a commer-
cially available potentiostat module (234). This also contributes to the last WHO
demand, which is for a device to be deliverable (i.e. portable and hand-held).
5.4 Future scope
To be amenable to real-world deployment, a number of issues must be addressed
for each sensing platform. For dendrites, the first is the highly variable nature
of dendrite growth, which can result in inconsistencies in peak current chip-to-
chip. We believe that growing dendrites on a pillar array, or indeed even ECC
arrays, may result in more homogeneous crystal formation. This may be due to
both the concentration of electric fields at sharp edges, as well as the fact that
the tip of a pillar array would extend into the HAuCl4 solution, meaning crystals
will preferentially form there faster. From there, we can optimize the deposition
time to isolate crystal growth largely to the core. A dendritic ECC chip may
even represent a significantly more sensitive device, by combining the nanoscale
proximity of the WE and the CE with an increase in surface area.
The process of reagent application and washing must also be addressed. In its
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current iteration, all steps must be done by hand, which is far too laborious
to have true POC utility. A microfluidic channel system should be fabricated
which allows for analysis with just sample application, such as that fabricated
by Numthuam, et. al., which was similarly used for an electrochemical ELISA
(235). Their work additionally showed that in a microfluidic device, a planar
electrode is only exposed to about half as much analyte as a pillar architecture,
which makes an argument for the utility of a dendritic electrode in such a setup.
Finally, a strategy towards either drastically reducing primary antibody tether-
ing time, or alternatively preserving pre-tethered antibodies should be explored.
As the protocol currently stands, a chip requires 48 hours of primary antibody
incubation for sufficient electrostatic bonding to occur. If this step were to be
hypothetically completed in manufacture, the chip must be kept wet and refrig-
erated until it reaches the end user, which is not a desirable feature for a POC tool
as the WHO suggests tools not need to maintain a cold chain. Instead, embed-
ding antibodies within the pyrrole matrix can be explored, which has been used
for immobilizing sensing components (114, 236). This method is not without its
own drawbacks, such as a lack of directed orientation of antibodies, which can
impact sensitivity. Antibody could also be stored as a lyophilized state on the
sensing region and re-hydrated at the site of the patient. Such a strategy would
necessitate a faster binding protocol than the electrostatic one detailed here.
5.4. Future scope 201
For ECC chips, the drawbacks are nearly identical. The same need for miniatur-
izing and automating analysis persists, given the similarity of the electrochem-
ical setup. Issues related to manufacturing inconsistencies must be addressed.
It is speculated that scaling up the process may aid this aim, as currently ECCs
are made stepwise, one at a time. This is likely where chip-to-chip variability
issues arise. Intra-chip variabilities remain an issue, whose cause is currently
unknown. Further investigation may reveal why arrays within the same chip do
not show the same FCA response, and provide an avenue to remedy this prob-
lem. Functionalization of ECCs presents the same issue seen in dendrites where
the protein must remain wet and refrigerated. However, the protein G tethering
protocol only takes 2 hours, and so there is some potential for on-site rehydration
as an alternative.
While numerous, these issues are not insurmountable, and indeed have already
been overcome by numerous ELISA LOC-type platforms (31, 35, 237–239).
Low-cost, POC diagnosis has the potential to be the intervention necessary to
achieve the WHO’s goal of a 90% reduction in cholera cases in the next decade.
With further development, these architectures may be able to provide invaluable
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